UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-Q
(Mark One)
 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended September 30, 2019
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from __________ to __________
 
Commission File Number: 1-36346
 
OXBRIDGE RE HOLDINGS LIMITED
(Exact name of registrant as specified in its charter)
 
Cayman Islands
 
98-1150254
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
 
Suite 20142 Edward Street, GeorgetownP.O. Box 469
Grand Cayman, Cayman Islands
 
KY1-9006
(Address of principal executive offices)
 
(Zip Code)
 
Registrant’s telephone number, including area code: (345) 749-7570
 
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
 
Yes      ☒
 
No            ☐
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
 
Yes     ☒
 
No            ☐
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer   ☐
 
Accelerated filer    ☐
Non-accelerated filer   ☐
 
Smaller reporting company   ☒
Emerging growth company  ☒
 
 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ______
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
 
Yes     ☐
 
No             ☒
 
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
 
As of November 4, 2019; 5,733,587 ordinary shares, par value $0.001 per share, were outstanding.
 

 
 
 
OXBRIDGE RE HOLDINGS LIMITED
 
INDEX
 
PART I – FINANCIAL INFORMATION
Page
 
 
 
Item 1.
Financial Statements
 
 
 
 
 
Consolidated Balance Sheets September 30, 2019 (unaudited) and December 31, 2018
3
 
 
 
 
Consolidated Statements of Operations Three and Nine Months Ended September 30, 2019 and 2018 (unaudited)
4
 
 
 
 
Consolidated Statements of Comprehensive (Loss) Income Three and Nine Months Ended September 30, 2019 and 2018 (unaudited)
5
 
 
 
 
Consolidated Statements of Cash Flows Nine Months Ended September 30, 2019 and 2018 (unaudited)
6
 
 
 
 
Consolidated Statements of Changes in Shareholders’ Equity Three and Nine Months Ended September 30, 2019 and 2018 (unaudited)
8
 
 
 
 
Notes to Consolidated Financial Statements (unaudited) 
9
 
 
 
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
31
 
 
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
43
 
 
 
Item 4.
Controls and Procedures 
43
 
 
PART II – OTHER INFORMATION
 
 
 
 
Item 1.
Legal Proceedings 
44
 
 
 
Item 1A.
Risk Factors 
44
 
 
 
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
44
 
 
 
Item 3.
Defaults Upon Senior Securities 
44
 
 
 
Item 4.
Mine Safety Disclosures 
44
 
 
 
Item 5.
Other Information 
44
 
 
 
Item 6.
Exhibits 
44
 
 
 
 
Signatures 
45
 

 
 
2
 
 
PART I - FINANCIAL INFORMATION
 
Item 1. Financial Statements
 
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
 
Consolidated Balance Sheets
(expressed in thousands of U.S. Dollars, except per share and share amounts)
 
 
 
At September 30,
2019
 
 
At December 31,
2018
 
 
 
(Unaudited)
 
 
 
 
Assets
 
 
 
 
 
 
Investments:
 
 
 
 
 
 
Fixed-maturity securities, available for sale, at fair value (amortized cost of $991 in 2018)
 $- 
  993 
Equity securities, at fair value (cost of $612 and $210 respectively)
  584 
  162 
       Total investments
  584 
  1,155 
Cash and cash equivalents
  6,137 
  8,074 
Restricted cash and cash equivalents
  1,915 
  3,225 
Accrued interest and dividend receivable
  11 
  15 
Premiums receivable
  837 
  - 
Deferred policy acquisition costs
  82 
  - 
Operating lease right-of-use assets
  140 
  - 
Prepayment and other assets
  73 
  74 
Property and equipment, net
  11 
  18 
  Total assets
 $9,790 
  12,561 
 
    
    
Liabilities and Shareholders’ Equity
    
    
Liabilities:
    
    
Reserve for losses and loss adjustment expenses
 $107 
  4,108 # 
Notes payable to Series 2019-1 noteholders
  600 
  - 
Unearned premiums reserve
  744 
  - 
Operating lease liabilities
  140 
  - 
Accounts payable and other liabilities
  226 
  139 
  Total liabilities
  1,817 
  4,247 
 
    
    
Shareholders’ equity:
    
    
Ordinary share capital, (par value $0.001, 50,000,000 shares authorized; 5,733,587 shares issued and outstanding)
  6 
  6 
Additional paid-in capital
  32,253 
  32,226 
Accumulated Deficit
  (24,286)
  (23,920)
Accumulated other comprehensive income
  - 
  2 
Total shareholders’ equity
  7,973 
  8,314 
Total liabilities and shareholders’ equity
 $9,790 
  12,561 
 
The accompanying Notes to Consolidated Financial Statements are an integral
part of the Consolidated Financial Statements.
 
 
3
 
 
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
 Consolidated Statements of Operations
(Unaudited)
(expressed in thousands of U.S. Dollars, except per share amounts)
 
 
 
Three Months Ended
 
 
Nine Months Ended
 
 
 
 September 30,
 
 
 September 30,
 
 
 
2019
 
 
2018
 
 
2019
 
 
2018
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue
 
 
 
 
 
 
 
 
 
 
 
 
Assumed premiums
 $- 
  47 
  1,116 
  2,627 
Change in loss experience refund payable
  - 
  - 
  - 
  (225)
Change in unearned premiums reserve
  279 
  653 
  (744)
  (1,148)
 
    
    
    
    
Net premiums earned
  279 
  700 
  372 
  1,254 
Net income from derivative instruments
  - 
  397 
  - 
  773 
Net investment and other income
  54 
  100 
  182 
  280 
         Net realized investment losses
  - 
  (61)
  3 
  (237)
         Change in fair value of equity securities
  17 
  118 
  20 
  22 
 
    
    
    
    
Total revenue
  350 
  1,254 
  577 
  2,092 
 
    
    
    
    
Expenses
    
    
    
    
Net Loss on commutation
  - 
  - 
  - 
  8 
Policy acquisition costs and underwriting expenses
  31 
  63 
  41 
  101 
General and administrative expenses
  264 
  305 
  808 
  981 
 
    
    
    
    
Total expenses
  295 
  368 
  849 
  1,090 
 
    
    
    
    
Income (loss) before (income) attributable to Series 2019-1 noteholders
 $55 
  886 
  (272)
  1,002 
 
    
    
    
    
(Income) attributable to Series 2019-1 noteholders
  (70)
  (234)
  (94)
  (296)
 
    
    
    
    
Net (loss) income
 $(15)
  652 
  (366)
  706 
 
    
    
    
    
(Loss) Earnings per share
    
    
    
    
Basic and Diluted
 $(0.00)
  0.11 
  (0.06)
  0.12 
 
    
    
    
    
Dividends paid per share
 $- 
  - 
  - 
  - 
 
The accompanying Notes to Consolidated Financial Statements are an integral
part of the Consolidated Financial Statements.
 
 
4
 
 
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
 Consolidated Statements of Comprehensive (Loss) Income
(Unaudited)
(expressed in thousands of U.S. Dollars)
 
 
 
Three Months Ended
 
 
Nine Months Ended
 
 
 
September 30,
 
 
September 30,
 
 
 
2019
 
 
2018
 
 
2019
 
 
2018
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net (loss) income
 $(15)
  652 
  (366)
  706 
Other comprehensive income (loss):
    
    
    
    
Change in unrealized loss on investments:
    
    
    
    
Unrealized (loss) gain arising during the period
  - 
  1 
  1 
  (3)
Reclassification adjustment for net realized losses (gains) included in net (loss) income
  - 
  - 
  (3)
  - 
 
    
    
    
    
Net change in unrealized loss
  - 
  1 
  (2)
  (3)
 
    
    
    
    
Total other comprehensive income (loss)
  - 
  1 
  (2)
  (3)
 
    
    
    
    
Comprehensive (loss) income
 $(15)
  653 
  (368)
  703 
 
The accompanying Notes to Consolidated Financial Statements are an integral
part of the Consolidated Financial Statements.
 
 
5
 
 
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
 Consolidated Statements of Cash Flows
(Unaudited)
(expressed in thousands of U.S. Dollars)
 
 
 
Nine Months Ended
 
 
 
September 30,
 
 
 
2019
 
 
2018
 
Operating activities
 
 
 
 
 
 
Net (loss) income
 $(366)
  706 
Adjustments to reconcile net (loss) income to net cash used in operating activities:
    
    
Stock-based compensation
  27 
  94 
Net amortization of premiums on investments in fixed-maturity securities
  - 
  7 
Depreciation and amortization
  7 
  14 
Net realized investment (gains) losses
  (3)
  237 
       Change in fair value of equity securities
  (20)
  (22)
Change in operating assets and liabilities:
    
    
Accrued interest and dividend receivable
  4 
  3 
Premiums receivable
  (837)
  1,718 
Deferred policy acquisition costs
  (82)
  (143)
Prepayment and other assets
  1 
  45 
Reserve for losses and loss adjustment expenses
  (4,001)
  (4,669)
Loss experience refund payable
  - 
  (135)
Losses payable
  - 
  (386)
Unearned premiums reserve
  744 
  (272)
Accounts payable and other liabilities
  87 
  589 
 
    
    
Net cash used in operating activities
 $(4,439)
  (2,214)
 
    
    
Investing activities
    
    
Purchase of fixed-maturity securities
  - 
  (4,902)
Purchase of equity securities
  (402)
  (5,804)
Proceeds from sale of fixed-maturity and equity securities
  994 
  12,181 
 
    
    
Net cash provided by investing activities
 $592 
  1,475 
 
    
    
Financing activities
    
    
Proceeds on issuance of notes payable to Series 2019-1 noteholders
  600 
  2,000 
 
    
    
Net cash provided by financing activities
 $600 
  2,000 
 
 
6
 
 
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
 Consolidated Statements of Cash Flows, continued
(Unaudited)
(expressed in thousands of U.S. Dollars)
 
 
 
Nine Months Ended
 
 
 
September 30,
 
 
 
2019
 
 
2018
 
 
 
 
 
 
 
 
Cash and cash equivalents, and restricted cash and cash equivalents:
 
 
 
 
 
 
Net change during the period
  (3,247)
  1,261 
Balance, beginning of period
  11,299 
  10,887 
 
    
    
Balance, end of period
 $8,052 
  12,148 
 
    
    
Supplemental disclosure of cash flow information
    
    
Interest paid
 $- 
  - 
Income taxes paid
 $- 
  - 
 
    
    
Non-cash investing activities
    
    
Net change in unrealized loss on securities available for sale
 $(2)
  (3)
Operating lease right-of-use assets
 $140 
  - 
Operating lease liability
 $140 
  - 
 
The accompanying Notes to Consolidated Financial Statements are an integral
part of the Consolidated Financial Statements.
 
 
7
 
 
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
Consolidated Statements of Changes in Shareholders’ Equity (unaudited)
 Three and Nine Months Ended September 30, 2019 and 2018
(expressed in thousands of U.S. Dollars, except share amounts)
 
 
 
Ordinary Share Capital
 
 
Additional Paid-in
 
 
Accumulated
 
 
Accumulated Other Comprehensive
 
 
Total Shareholders'
 
 
 
Shares
 
 
Amount
 
 
Capital
 
 
Deficit
 
 
Loss
 
 
Equity
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance at December 31, 2017
  5,733,587 
  6 
  32,100 
  (18,149)
  (39)
  13,918 
Cumulative effect of change in accounting for equity securities as of January 1, 2018
  - 
  - 
  - 
  (22)
  22 
  - 
Net loss for the period
  - 
  - 
  - 
  (211)
  - 
  (211)
Stock-based compensation
  - 
  - 
  31 
  - 
  - 
  31 
Total other comprehensive loss
  - 
  - 
  - 
  - 
  (3)
  (3)
Balance at March 31, 2018
  5,733,587 
  6 
  32,131 
  (18,382)
  (20)
  13,735 
Net income for the period
  - 
  - 
  - 
  265 
  - 
  265 
Stock-based compensation
  - 
  - 
  32 
  - 
  - 
  32 
Total other comprehensive loss
  - 
  - 
  - 
  - 
  (1)
  (1)
Balance at June 30, 2018
  5,733,587 
  6 
  32,163 
  (18,117)
  (21)
  14,031 
Net income for the period
  - 
  - 
  - 
  652 
  - 
  652 
Stock-based compensation
  - 
  - 
  31 
  - 
  - 
  31 
Total other comprehensive income
  - 
  - 
  - 
  - 
  1 
  1 
Balance at September 30, 2018
  5,733,587 
  6 
  32,194 
  (17,465)
  (20)
  14,715 
 
    
    
    
    
    
    
 
    
    
    
    
    
    
Balance at December 31, 2018
  5,733,587 
  6 
  32,226 
  (23,920)
  2 
  8,314 
Net loss for the period
  - 
  - 
  - 
  (146)
  - 
  (146)
Stock-based compensation
  - 
  - 
  9 
  - 
  - 
  9 
Total other comprehensive loss
  - 
  - 
  - 
  - 
  (2)
  (2)
Balance at March 31, 2019
  5,733,587 
  6 
  32,235 
  (24,066)
  - 
  8,175 
Net loss for the period
  - 
  - 
  - 
  (205)
  - 
  (205)
Stock-based compensation
  - 
  - 
  9 
  - 
  - 
  9 
Balance at June 30, 2019
  5,733,587 
  6 
  32,244 
  (24,271)
  - 
  7,979 
Net loss for the period
  - 
  - 
  - 
  (15)
  - 
  (15)
Stock-based compensation
  - 
  - 
  9 
  - 
  - 
  9 
Balance at September 30, 2019
  5,733,587 
  6 
  32,253 
  (24,286)
  - 
  7,973 
 
The accompanying Notes to Consolidated Financial Statements are an integral
part of the Consolidated Financial Statements.
 
 
8
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
Notes to Consolidated Financial Statements (unaudited)
September 30, 2019
 
1.
ORGANIZATION AND BASIS OF PRESENTATION
 
(a)
Organization
 
Oxbridge Re Holdings Limited (the “Company”) was incorporated as an exempted company on April 4, 2013 under the laws of the Cayman Islands. Oxbridge Re Holdings Limited owns 100% of the equity interest in Oxbridge Reinsurance Limited, an exempted entity incorporated on April 23, 2013 under the laws of the Cayman Islands and for which a Class “C” Insurer’s license was granted on April 29, 2013 under the provisions of the Cayman Islands Insurance Law. Oxbridge Re Holdings Limited also owns 100% of the equity interest in Oxbridge Re NS, an entity incorporated as an exempted company on December 22, 2017 under the laws of the Cayman Islands to function as a reinsurance sidecar facility and to increase the underwriting capacity of Oxbridge Reinsurance Limited. The Company, through its subsidiaries (collectively “Oxbridge Re”) provides collateralized reinsurance in the property catastrophe market and invests in various insurance-linked securities. The Company operates as a single business segment through its wholly-owned subsidiaries. The Company’s headquarters and principal executive offices are located at Suite 201, 42 Edward Street, Georgetown, Grand Cayman, Cayman Islands, and have their registered offices at P.O. Box 309, Ugland House, Grand Cayman, Cayman Islands.
 
The Company’s ordinary shares and warrants are listed on The NASDAQ Capital Market under the symbols “OXBR” and “OXBRW,” respectively.
 
(b)
Basis of Presentation and Consolidation
 
The accompanying unaudited, consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information, and the Securities and Exchange Commission (“SEC”) rules for interim financial reporting. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with GAAP have been omitted pursuant to such rules and regulations. However, in the opinion of management, the accompanying interim consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the Company’s consolidated financial position as of September 30, 2019 and the consolidated results of operations and cash flows for the periods presented. The consolidated results of operations for interim periods are not necessarily indicative of the results of operations to be expected for any subsequent interim period or for the fiscal year ended December 31, 2019. The accompanying unaudited consolidated financial statements and notes thereto should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2018 included in the Company’s Form 10-K, which was filed with the SEC on March 19, 2019.
 
In preparing the interim unaudited consolidated financial statements, management was required to make certain estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and related disclosures at the financial reporting date and throughout the periods being reported upon. Certain of the estimates result from judgments that can be subjective and complex and consequently actual results may differ from these estimates, which would be reflected in future periods.
 
 
9
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
Notes to Consolidated Financial Statements (unaudited)
September 30, 2019
 
Material estimates that are particularly susceptible to significant change in the near-term relate to the determination of the reserve for losses and loss adjustment expenses, which include amounts estimated for claims incurred but not yet reported. The Company uses various assumptions and actuarial data it believes to be reasonable under the circumstances to make these estimates. In addition, accounting policies specific to valuation of investments and assessment of other-than-temporary impairment (“OTTI”) may involve significant judgments and estimates material to the Company’s consolidated financial statements. Although considerable variability is likely to be inherent in these estimates, management believes that any amounts provided are reasonable. These estimates are continually reviewed and adjusted if necessary. Such adjustments are reflected in current operations.
 
The Company consolidates in these consolidated financial statements the results of operations and financial position of all voting interest entities (“VOE”) in which the Company has a controlling financial interest and all variable interest entities (“VIE”) in which the Company is considered to be the primary beneficiary. The consolidation assessment, including the determination as to whether an entity qualifies as a VIE or VOE, depends on the facts and circumstances surrounding each entity.
 
All significant intercompany balances and transactions have been eliminated.
 
2.
SIGNIFICANT ACCOUNTING POLICIES
 
Cash and cash equivalents: Cash and cash equivalents are comprised of cash and short- term investments with original maturities of three months or less.
 
Restricted cash and cash equivalents: Restricted cash and cash equivalents represent funds held in accordance with the Company’s trust agreements with ceding insurers and trustees, which requires the Company to maintain collateral with a market value greater than or equal to the limit of liability, less unpaid premium.
 
Investments: The Company’s investments consist of fixed-maturity securities and equity securities, and for which its fixed-maturity securities are classified as available-for-sale. The Company’s available for sale investments are carried at fair value with changes in fair value included as a separate component of accumulated other comprehensive income in shareholders’ equity. For the Company’s investment in equity securities, the changes in fair value are recorded within the consolidated statements of operations.
 
Unrealized gains or losses are determined by comparing the fair market value of the securities with their cost or amortized cost. Realized gains and losses on investments are recorded on the trade date and are included in the consolidated statements of operations. The cost of securities sold is based on the specified identification method. Investment income is recognized as earned and discounts or premiums arising from the purchase of debt securities are recognized in investment income using the interest method over the remaining term of the security.
 
 
10
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
Notes to Consolidated Financial Statements (unaudited)
September 30, 2019
 
The Company reviews all fixed-maturity securities for other-than-temporary impairment on a quarterly basis and more frequently when economic or market conditions warrant such review. When the fair value of any investment is lower than its cost, an assessment is made to see whether the decline is temporary or other-than-temporary. If the decline is determined to be other-than-temporary the investment is written down to fair value and an impairment charge is recognized in operations in the period in which the Company makes such determination. For a fixed-maturity security that the Company does not intend to sell nor is it more likely than not that the Company will be required to sell before recovery of its amortized cost, only the credit loss component is recognized in operations, while impairment related to all other factors is recognized in other comprehensive income. The Company considers various factors in determining whether an individual security is other-than-temporarily impaired.
 
Fair value measurement: GAAP establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under GAAP are as follows:
 
Level 1
Inputs that reflect unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date;
 
 
Level 2
Inputs other than quoted prices that are observable for the asset or liability either directly or indirectly, including inputs in markets that are not considered to be active; and
 
 
Level 3
Inputs that are unobservable.
 
Inputs are used in applying the various valuation techniques and broadly refer to the assumptions that market participants use to make valuation decisions, including assumptions about risk. For fixed maturity securities, inputs may include price information, volatility statistics, specific and broad credit data, liquidity statistics, broker quotes for similar securities and other factors. The fair value of investments in stocks and exchange-traded funds is based on the last traded price. A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. However, the determination of what constitutes “observable” requires significant judgment by the Company’s investment custodians. The investment custodians consider observable data to be market data which is readily available, regularly distributed or updated, reliable and verifiable, not proprietary, and provided by independent sources that are actively involved in the relevant markets. The categorization of a financial instrument within the hierarchy is based upon the pricing transparency of the instrument.
 
 
11
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
Notes to Consolidated Financial Statements (unaudited)
September 30, 2019
 
Derivative Financial Instruments: The Company may from time to time enter into underwriting contracts such as industry loss warranty contracts (“ILW”) that are treated as derivatives for GAAP purposes. GAAP requires that an entity recognize all derivatives in the consolidated balance sheet at fair value. It also requires that unrealized gains and losses resulting from changes in fair value be included in operations or comprehensive (loss) income. The Company did not have any derivative financial assets at September 30, 2019 or December 31, 2018. There were no derivative financial liabilities at September 30, 2019, and all derivative financial liabilities at December 31, 2018 have been included within reserve for losses and loss adjustment expenses.
 
Deferred policy acquisition costs (“DAC”): Policy acquisition costs consist of brokerage fees, federal excise taxes and other costs related directly to the successful acquisition of new or renewal insurance contracts and are deferred and amortized over the terms of the reinsurance agreements to which they relate. The Company evaluates the recoverability of DAC by determining if the sum of future earned premiums and anticipated investment income is greater than the expected future claims and expenses. If a loss is probable on the unexpired portion of policies in force, a premium deficiency loss is recognized. At September 30, 2019, the DAC was considered fully recoverable and no premium deficiency loss was recorded.
 
Property and equipment:  Property and equipment are recorded at cost when acquired. Property and equipment are comprised of motor vehicles, furniture and fixtures, computer equipment and leasehold improvements and are depreciated, using the straight-line method, over their estimated useful lives, which are five years for furniture and fixtures and computer equipment and four years for motor vehicles. Leasehold improvements are amortized over the lesser of the estimated useful lives of the assets or remaining lease term. The Company periodically reviews property and equipment that have finite lives, and that are not held for sale, for impairment by comparing the carrying value of the assets to their estimated future undiscounted cash flows. For the three-month and nine-month periods ended September 30, 2019 and 2018, there were no impairments in property and equipment.
 
Allowance for uncollectible receivables: Management evaluates credit quality by evaluating the exposure to individual counterparties; where warranted management also considers the credit rating or financial position, operating results and/or payment history of the counterparty. Management establishes an allowance for amounts for which collection is considered doubtful. Adjustments to previous assessments are recognized as income in the year in which they are determined. At September 30, 2019, no receivables were determined to be overdue or impaired and, accordingly, no allowance for uncollectible receivables has been established.
 
Reserves for losses and loss adjustment expenses: The Company determines its reserves for losses and loss adjustment expenses on the basis of the claims reported by the Company’s ceding insurers and for losses incurred but not reported (“IBNR”), management uses the assistance of an independent actuary. The reserves for losses and loss adjustment expenses represent management’s best estimate of the ultimate settlement costs of all losses and loss adjustment expenses. Management believes that the amounts are adequate; however, the inherent impossibility of predicting future events with precision, results in uncertainty as to the amount which will ultimately be required for the settlement of losses and loss expenses, and the differences could be material. Adjustments are reflected in the consolidated statements of operations in the period in which they are determined.
 
 
12
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
Notes to Consolidated Financial Statements (unaudited)
September 30, 2019
 
Loss experience refund payable: Certain contracts may include retrospective provisions that adjust premiums or result in profit commissions in the event losses are minimal or zero. In accordance with GAAP, the Company will recognize a liability in the period in which the absence of loss experience obligates the Company to pay cash or other consideration under the contracts. On the contrary, the Company will derecognize such liability in the period in which a loss experience arises. Such adjustments to the liability, which accrue throughout the contract terms, will reduce the liability should a catastrophic loss event covered by the Company occur.
 
Premiums assumed: The Company records premiums assumed, net of loss experience refunds, as earned pro-rata over the terms of the reinsurance agreements, or period of risk, where applicable, and the unearned portion at the consolidated balance sheet date is recorded as unearned premiums reserve. A reserve is made for estimated premium deficiencies to the extent that estimated losses and loss adjustment expenses exceed related unearned premiums. Investment income is not considered in determining whether or not a deficiency exists.
 
Subsequent adjustments of premiums assumed, based on reports of actual premium by the ceding companies, or revisions in estimates of ultimate premium, are recorded in the period in which they are determined. Such adjustments are generally determined after the associated risk periods have expired, in which case the premium adjustments are fully earned when assumed.
 
Certain contracts may allow for reinstatement premiums in the event of a full limit loss prior to the expiration of the contract. A reinstatement premium is not due until there is a full limit loss event and therefore, in accordance with GAAP, the Company records a reinstatement premium as written only in the event that the reinsured incurs a full limit loss on the contract and the contract allows for a reinstatement of coverage upon payment of an additional premium. For catastrophe contracts which contractually require the payment of a reinstatement premium equal to or greater than the original premium upon the occurrence of a full limit loss, the reinstatement premiums are earned over the original contract period. Reinstatement premiums that are contractually calculated on a pro-rata basis of the original premiums are earned over the remaining coverage period.
 
Unearned Premiums Ceded: The Company reduces the risk of future losses on business assumed by reinsuring certain risks and exposures with other reinsurers (retrocessionaires). The Company remains liable to the extent that any retrocessionaire fails to meet its obligations and to the extent that the Company does not hold sufficient security for their unpaid obligations.
 
Ceded premiums are written during the period in which the risk incept and are expensed over the contract period in proportion to the period of protection. Unearned premiums ceded consist of the unexpired portion of the reinsurance obtained.
 
Uncertain income tax positions: The authoritative GAAP guidance on accounting for, and disclosure of, uncertainty in income tax positions requires the Company to determine whether an income tax position of the Company is more likely than not to be sustained upon examination by the relevant tax authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position.
For income tax positions meeting the more likely than not threshold, the tax amount recognized in the consolidated financial statements, if any, is reduced by the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement with the relevant taxing authority. The application of this authoritative guidance has had no effect on the Company’s consolidated financial statements because the Company had no uncertain tax positions at September 30, 2019.
 
 
13
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
Notes to Consolidated Financial Statements (unaudited)
September 30, 2019
 
(Loss) Earnings Per Share: Basic (loss) earnings per share has been computed on the basis of the weighted-average number of ordinary shares outstanding during the periods presented. Diluted (loss) earnings per share is computed based on the weighted-average number of ordinary shares outstanding and reflects the assumed exercise or conversion of diluted securities, such as stock options and warrants, computed using the treasury stock method.
 
Stock-Based Compensation: The Company accounts for stock-based compensation under the fair value recognition provisions of GAAP which requires the measurement and recognition of compensation for all stock-based awards made to employees and directors, including stock options and restricted stock issuances based on estimated fair values. The Company measures compensation for restricted stock based on the price of the Company’s ordinary shares at the grant date. Determining the fair value of stock options at the grant date requires significant estimation and judgment. The Company uses an option-pricing model (Black-Scholes option pricing model) to assist in the calculation of fair value for stock options. The Company's shares have not been publicly traded for a sufficient length of time to solely use the Company's performance to reasonably estimate the expected volatility. Therefore, when estimating the expected volatility, the Company takes into consideration the historical volatility of similar entities. The Company considers factors such as an entity's industry, stage of life cycle, size and financial leverage when selecting similar entities. The Company may use a sample peer group of companies in the reinsurance industry and/or the Company’s own historical volatility in determining the expected volatility. Additionally, the Company uses the full life of the options, ten years, as the estimated term of the options, and has assumed no forfeitures during the life of the options.
 
The Company uses the straight-line attribution method for all grants that include only a service condition. Compensation expense related to all awards is included in general and administrative expenses. 
 
Recent Adopted Accounting Pronouncements:
 
Accounting Standards Update No. 2016-02. In February 2016, the FASB issued ASU 2016-02, "Leases (Topic 842)," which supersedes Topic 840 and creates the new lease accounting standards for lessees and lessors, primarily related to the recognition of lease assets and liabilities by lessees for leases classified as operating leases. Under previous guidance for lessees, leases were only included on the balance sheet if certain criteria, classifying the agreement as a capital lease, were met. This update requires the recognition of a right-of-use asset and a corresponding lease liability, discounted to the present value, for all leases that extend beyond 12 months.
 
For operating leases, the asset and liability are expensed over the lease term on a straight-line basis, with all cash flows included in the operating section of the statement of cash flows. For finance leases, interest on the lease liability is recognized separately from the amortization of the right-of-use asset in the consolidated statement of comprehensive operations and the repayment of the principal portion of the lease liability is classified as a financing activity while the interest component is included in the operating section of the consolidated statement of cash flows.
 
 
 
14
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
Notes to Consolidated Financial Statements (unaudited)
September 30, 2019
 
We adopted ASU 2016-02, ASU 2018-10 Codification Improvements to Topic 842: Leases and ASU 2018-11 Leases (Topic 842): Targeted Improvements on January 1, 2019.  We applied the standards using the alternative transition method provided by ASU 2018-11 under which leases were recognized at the date of adoption and a cumulative-effective adjustment to the opening balance of retained earnings would have been recognized in the period of adoption. As the standard did not have an impact on our net (loss) earnings, no adjustment to the opening balance of retained earnings was required. As of September 30, 2019, $140 thousand of right-of-use assets and $140 thousand of lease liabilities for operating leases were added as operating lease right-of-use assets and operating lease liabilities line items, respectively, on the consolidated balance sheet as a result of the adoption of this update. We implemented controls for the adoption of the standard and the ongoing monitoring of the right-of-use asset and lease liability, but they did not materially affect our internal control over financial reporting.
 

Pending Accounting Updates:
 
 Accounting Standards Update No. 2016-13. In June 2016, the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurements of Credit Losses on Financial Instruments” (“ASU 2016-13”). ASU 2016-13 amends the guidance on reporting credits losses and affects loans, debt securities, trade receivables, reinsurance recoverable and other financial assets that have the contractual right to receive cash. The amendments are effective for annual periods beginning after December 15, 2019, and interim periods within those annual periods. The Company is in the process of evaluating the impact of the requirements of ASU 2016-13 on the Company’s consolidated financial statements and anticipates implementing ASU 2016-13 during the first quarter of fiscal year 2020. In July 2019, the FASB board voted to ask its staff to prepare an exposure draft proposing the new effective dates for ASU No. 2016-13. If approved, the new effective date for the Company would be January 1, 2023.
 
Accounting Standards Update No. 2018-13. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820) - Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement (“ASU 2018-13”).  ASU 2018-13 removes, modifies and adds certain disclosure requirements associated with fair value measurements. ASU 2018-13 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019.  The removed and modified disclosures will be adopted on a retrospective basis and the new disclosures will be adopted on a prospective basis. We are currently evaluating our timeline for the adoption of this ASU, which only affects the presentation of certain disclosures and is not expected to impact our results of operations, financial position or liquidity.
 
 
15
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
Notes to Consolidated Financial Statements (unaudited)
September 30, 2019
 
Segment Information: Under GAAP, operating segments are based on the internal information that management uses for allocating resources and assessing performance as the source of the Company’s reportable segments. The Company manages its business on the basis of one operating segment, Property and Casualty Reinsurance, in accordance with the qualitative and quantitative criteria established under GAAP.
 
Reclassifications: Any reclassifications of prior period amounts have been made to conform to the current period presentation.
 
3.
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS
 
 
 
At September 30,
 
 
At December 31,
 
 
 
2019
 
 
2018
 
 
 
(in thousands)
 
 
 
 
 
 
 
 
Cash on deposit
 $3,468 
 $3,965 
Cash held with custodians
  2,669 
  4,109 
Restricted cash held in trust
  1,915 
  3,225 
 
    
    
Total
 $8,052 
 $11,299 
 
Cash and cash equivalents are held by large and reputable counterparties in the United States of America and in the Cayman Islands. Restricted cash held in trust is custodied with SunTrust Bank and is held in accordance with the Company’s trust agreements with the ceding insurers and trustees, which require that the Company provide collateral having a market value greater than or equal to the limit of liability, less unpaid premium.
 
4. INVESTMENTS
 
The Company from time to time invests in fixed-maturity securities and equity securities, with its fixed-maturity securities classified as available-for-sale. At September 30, 2019, the Company did not hold any available-for-sale securities. At December 31, 2018, the cost or amortized cost, gross unrealized gains and losses, and estimated fair value of the Company’s available-for-sale securities by security type were as follows:
 
 
 
Cost or
Amortized
Cost
 
 
Gross
Unrealized
Gain
 
 
Gross
Unrealized
Loss
 
 
Estimated
Fair
Value ($000)
 
 
 
($ in thousands)
 
As of December 31, 2018
 
 
 
 
 
 
 
 
 
 
 
 
Fixed-maturity securities
 
 
 
 
 
 
 
 
 
 
 
 
U.S. Treasury and agency securities
 $991 
 $2 
 $- 
 $993 
 
At December 31, 2018, available-for-sale securities with fair value of $993,000, was held in trust accounts as collateral under reinsurance contacts with the Company’s ceding insurers.
 
All of the Company's available for sale securities had scheduled contractual maturities after one year and through five years at December 31, 2018.
 
 
16
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
Notes to Consolidated Financial Statements (unaudited)
September 30, 2019
 
4. 
INVESTMENTS (continued)
 
There were no sales of available-for-sale fixed maturity or equity securities during the three-month period ended September 30, 2019. Proceeds received, and the gross realized gains and losses from sales of available-for-sale fixed-maturity securities, and equity securities, for the nine months ended September 30, 2019 and the three-months and nine-months ended September 30, 2018 were as follows:
 
 
 
Gross proceeds from sales
 
 
Gross
Realized
Gains
 
 
Gross
Realized
Losses
 
 
 
($ in thousands)
 
 
 
 
 
 
 
 
 
 
 
Nine Months Ended September 30, 2019
 
 
 
 
 
 
 
 
 
Available-for-sale fixed-maturity securities
 $994 
 $3 
 $- 
 
    
    
    
Three Months Ended September 30, 2018
    
    
    
Available-for-sale fixed-maturity securities
 $1,565 
 $3 
 $- 
 
    
    
    
Equity securities
 $1,583 
 $57 
 $(121)
 
    
    
    
Nine Months Ended September 30, 2018
    
    
    
Available-for-sale fixed-maturity securities
 $4,565 
 $3 
 $- 
 
    
    
    
Equity securities
 $7,616 
 $475 
 $(715)
 
The Company regularly reviews its individual investment securities for OTTI. The Company from time to time may hold debt securities and may consider various factors in determining whether each individual debt security is other-than-temporarily impaired, including:
 
the financial condition and near-term prospects of the issuer, including any specific events that may affect its operations or income;
 
the length of time and the extent to which the market value of the security has been below its cost or amortized cost;
 
general market conditions and industry or sector specific factors;
 
nonpayment by the issuer of its contractually obligated interest and principal payments; and
 
the Company’s intent and ability to hold the investment for a period of time sufficient to allow for the recovery of costs.
 
At December 31, 2018, there were no available-for-sale securities in an unrealized loss position.
 
 
17
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
Notes to Consolidated Financial Statements (unaudited)
September 30, 2019
 
4. 
INVESTMENTS (continued)
 
Assets Measured at Estimated Fair Value on a Recurring Basis
 
The following table presents information about the Company’s financial assets measured at estimated fair value on a recurring basis that is reflected in the consolidated balance sheets at carrying value. The table indicates the fair value hierarchy of the valuation techniques utilized by the Company to determine such fair value as of September 30, 2019 and December 31, 2018:
 
 
 
Fair Value Measurements Using
 
 
 
 
 
 
(Level 1)
 
 
(Level 2)
 
 
(Level 3)
 
 
Total
 
As of September 30, 2019
 
($ in thousands)
 
Financial Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 $6,137 
 $- 
 $- 
 $6,137 
 
    
    
    
    
Restricted cash and cash equivalents
 $1,915 
 $- 
 $- 
 $1,915 
 
    
    
    
    
   Total equity securities
  584 
  - 
  - 
  584 
 
    
    
    
    
Total
 $8,636 
 $- 
 $- 
 $8,636 
 
 
 
Fair Value Measurements Using
 
 
 
 
 
 
(Level 1)
 
 
(Level 2)
 
 
(Level 3)
 
 
Total
 
As of December 31, 2018
 
($ in thousands)
 
Financial Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 $8,074 
 $- 
 $- 
 $8,074 
 
    
    
    
    
Restricted cash and cash equivalents
 $3,225 
 $- 
 $- 
 $3,225 
 
    
    
    
    
U.S. Treasury and agency securities
  - 
  993 
  - 
  993 
 
    
    
    
    
 
    
    
    
    
Total fixed-maturity securities
  - 
  993 
  - 
  993 
 
    
    
    
    
Total equity securities
  162 
  - 
  - 
  162 
 
    
    
    
    
Total available for sale securities
  162 
  993 
  - 
  1,155 
 
    
    
    
    
Total
 $11,461 
 $993 
 $- 
 $12,454 
 
There were no transfers between Levels 1, 2 and 3 during the three and nine months ended September 30, 2019 and 2018.
 
 
18
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
Notes to Consolidated Financial Statements (unaudited)
September 30, 2019
 
5.  DERIVATIVE INSTRUMENTS
 
Inward Industry Loss Warranty ("ILW") Swap
 
In January 2018, the Company entered into an inward ILW swap (the "2018 Inward ILW Swap") with a third-party under which qualifying loss payments are triggered by reference to the level of losses incurred by the insurance industry as a whole, rather than by losses incurred by the insured. In return for a fixed payment received of $1 million, the Company was required to make a floating payment in the event of certain losses incurred from specified natural catastrophes in North America, Caribbean, Europe, Japan, Australia, New Zealand and Latin America from January 2018 to December 2018. The Company’s maximum payment obligation under the 2018 Inward ILW Swap was $4 million. The ILW Swap expired on December 31, 2018 and the Company did not renew the ILW Swap during the nine-month period ending September 30, 2019.
 
During the nine months ending September 30, 2019, the Company settled its payment obligation of $4 million under the 2018 Inward ILW Swap.
 
6.  TAXATION
 
Under current Cayman Islands law, no corporate entity, including the Company and the subsidiaries, is obligated to pay taxes in the Cayman Islands on either income or capital gains. The Company and its subsidiaries have an undertaking from the Governor-in-Cabinet of the Cayman Islands, pursuant to the provisions of the Tax Concessions Law, as amended, that, in the event that the Cayman Islands enacts any legislation that imposes tax on profits, income, gains or appreciations, or any tax in the nature of estate duty or inheritance tax, such tax will not be applicable to the Company and its subsidiaries or their operations, or to the ordinary shares or related obligations, until April 23, 2033 and May 17, 2033, respectively.
 
The Company and its subsidiaries intend to conduct substantially all of their operations in the Cayman Islands in a manner such that they will not be engaged in a trade or business in the U.S. However, because there is no definitive authority regarding activities that constitute being engaged in a trade or business in the U.S. for federal income tax purposes, the Company cannot assure that the U.S. Internal Revenue Service will not contend, perhaps successfully, that the Company or its subsidiary is engaged in a trade or business in the U.S. A foreign corporation deemed to be so engaged would be subject to U.S. federal income tax, as well as branch profits tax, on its income that is treated as effectively connected with the conduct of that trade or business unless the corporation is entitled to relief under an applicable tax treaty.
 
 
19
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
Notes to Consolidated Financial Statements (unaudited)
September 30, 2019
 
7. VARIABLE INTEREST ENTITIES
 
Oxbridge Re NS. On December 22, 2017, the Company established Oxbridge Re NS, a Cayman domiciled and licensed special purpose insurer, formed to provide additional collateralized capacity to support Oxbridge Reinsurance Limited’s reinsurance business. In respect of the debt issued by Oxbridge Re NS to investors, Oxbridge Re NS has entered into a retrocession agreement with Oxbridge Reinsurance Limited effective June 1, 2018. Under this agreement, Oxbridge Re NS receives a quota share of Oxbridge Reinsurance Limited’s catastrophe business. Oxbridge Re NS is a non-rated insurer and the risks have been fully collateralized by way of funds held in trust for the benefit of Oxbridge Reinsurance Limited. Oxbridge Re NS is able to provide investors with access to diversified natural catastrophe risk backed by the distribution, underwriting, analysis and research expertise of Oxbridge Re.
 
The Company has determined that Oxbridge Re NS meets the definition of a VIE as it does not have sufficient equity capital to finance its activities. The Company concluded that it is the primary beneficiary and has consolidated the subsidiary upon its formation, as it owns 100% of the voting shares, 100% of the issued share capital and has a significant financial interest and the power to control the activities of Oxbridge Re NS that most significantly impacts its economic performance. The Company has no other obligation to provide financial support to Oxbridge Re NS. Neither the creditors nor beneficial interest holders of Oxbridge Re NS have recourse to the Company’s general credit.
 
Upon issuance of a series of participating notes by Oxbridge Re NS, all of the proceeds from the issuance are deposited into collateral accounts, to fund any potential obligation under the reinsurance agreements entered into with Oxbridge Reinsurance Limited underlying such series of notes. The outstanding principal amount of each series of notes generally is expected to be returned to holders of such notes upon the expiration of the risk period underlying such notes, unless an event occurs which causes a loss under the applicable series of notes, in which case the amount returned is expected to be reduced by such noteholder's pro rata share of such loss, as specified in the applicable governing documents of such notes. In addition, holders of such notes are generally entitled to interest payments, payable annually, as determined by the applicable governing documents of each series of notes. Oxbridge Re Holdings Limited receives an origination and structuring fee in connection with the formation, operation and management of Oxbridge Re NS.
 
 
20
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
Notes to Consolidated Financial Statements (unaudited)
September 30, 2019
 
7. VARIABLE INTEREST ENTITIES (continued)
 
Notes Payable to Series 2019-1 noteholders
 
Oxbridge Re NS entered into a retrocession agreement with Oxbridge Reinsurance Ltd on June 1, 2019 and issued $600 thousand of participating notes which provides quota share support for Oxbridge Re’s global property catastrophe excess of loss reinsurance business. The participating notes have been assigned Series 2019-1 and are due to mature on June 1, 2022. None of the participating notes were redeemed during the period ending September 30, 2019.
 
The income from Oxbridge Re NS operations that are attributable to the participating notes noteholders for the three and nine month ended September 30, 2019 was $70,000 and $94,000 respectively and are included within accounts payable and other liabilities as at September 30, 2019.
 
Notes Payable to Series 2018-1 noteholders
 
Oxbridge Re NS issued $2 million of participating notes on June 1, 2018, all of which were issued to third parties and which provides quota share support for Oxbridge Re’s global property catastrophe excess of loss reinsurance business. The operations of Oxbridge Re NS commenced on June 1, 2018. The participating notes were due to mature on June 1, 2021. However, during the quarter ending December 31, 2018, the participating notes were triggered, and suffered full loss, and as a result, these notes were subsequently redeemed and cancelled.
 
 
21
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
Notes to Consolidated Financial Statements (unaudited)
September 30, 2019
 
8.  RESERVE FOR LOSSES AND LOSS ADJUSTMENT EXPENSES
 
The following table summarizes the Company’s loss and loss adjustment expenses (“LAE”) and the reserve for loss and LAE reserve movements for the three and nine-month periods ending September 30, 2019 and 2018:
 
 
 
Three Months Ended
 
 
Nine Months Ended
 
 
 
September 30,
 
 
September 30,
 
 
 
2019
 
 
2018
 
 
2019
 
 
2018
 
 
 
($ in thousands)
 
 
($ in thousands)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
 $107 
  167 
 $4,108 
  4,836 
Incurred related to:
    
    
    
    
     Current period
  - 
  - 
  - 
  - 
     Prior period 1
  - 
  - 
  - 
  (1,012)
           Total incurred
  - 
  - 
  - 
  (1,012)
Paid related to:
    
    
    
    
     Current period
  - 
  - 
  - 
  - 
     Prior period
  - 
  - 
  (4,001)
  (3,657)
           Total paid
  - 
  - 
  (4,001)
  (3,657)
Net balance, end of period
 $107 
  167 
 $107 
  167 
Add: reinsurance recoverable
  - 
  - 
  - 
  - 
Gross balance, end of period
 $107 
  167 
 $107 
  167 
 
The reserves for losses and LAE are comprised of case reserves (which are based on claims that have been reported) and IBNR reserves (which are based on losses that are believed to have occurred but for which claims have not yet been reported and include a provision for expected future development on existing case reserves). The Company uses the assistance of an independent actuary in the determination of IBNR and expected future development of existing case reserves.
 
The uncertainties inherent in the reserving process and potential delays by cedants and brokers in the reporting of loss information, together with the potential for unforeseen adverse developments, may result in the reserve for losses and LAE ultimately being significantly greater or less than the reserve provided at the end of any given reporting period. The degree of uncertainty is further increased when a significant loss event takes place near the end of a reporting period. Reserve for losses and LAE estimates are reviewed periodically on a contract by contract basis and updated as new information becomes known. Any resulting adjustments are reflected in operations in the period in which they become known.
 
The Company’s reserving process is highly dependent on the timing of loss information received from its cedants and related brokers.
 
 
22
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
Notes to Consolidated Financial Statements (unaudited)
September 30, 2019
 
9.  LOSS (EARNINGS) PER SHARE
 
A summary of the numerator and denominator of the basic and diluted loss (earnings) per share is presented below (dollars in thousands except per share amounts):
 
 
 
Three Months Ended
 
 
Nine Months Ended
 
 
 
 September 30,
 
 
 September 30,
 
 
 
2019
 
 
2018
 
 
2019
 
 
2018
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Numerator:
 
 
 
 
 
 
 
 
 
 
 
 
     Net (loss) earnings
 $(15)
  652 
 $(366)
  706 
 
    
    
    
    
Denominator:
    
    
    
    
    Weighted average shares - basic
  5,733,587 
  5,733,587 
  5,733,587 
  5,733,587 
    Effect of dilutive securities - Stock options
  - 
  - 
  - 
  - 
    Shares issuable upon conversion of warrants
  - 
  - 
  - 
  - 
    Weighted average shares - diluted
  5,733,587 
  5,733,587 
  5,733,587 
  5,733,587 
(Loss)/earnings per shares - basic
 $(0.00)
  0.11 
 $(0.06)
  0.12 
(Loss)/earnings per shares - diluted
 $(0.00)
  0.11 
 $(0.06)
  0.12 
 
For the three and nine-month periods ended September 30, 2019, options to purchase 540,000 ordinary shares, were anti-dilutive due to net loss during the periods presented. For the three and nine-month periods ended September 30, 2018, options to purchase 250,000 ordinary shares were anti-dilutive due to the sum of the proceeds, including unrecognized compensation expense, exceeded the average market price of the Company’s ordinary share during the periods presented.
 
For the three and nine-month periods ended September 30, 2019, 8,230,700 warrants to purchase an aggregate of 8,230,700 ordinary shares were anti-dilutive due to net loss during the periods presented. For the three and nine-month periods ended September 30, 2018, 8,230,700 warrants to purchase an aggregate of 8,230,700 ordinary shares were anti-dilutive because the exercise price of $7.50 exceeded the average market price of the Company’s ordinary share during the periods presented.
 
GAAP requires the Company to use the two-class method in computing basic (loss) earnings per share since holders of the Company’s restricted stock have the right to share in dividends, if declared, equally with common stockholders. These participating securities effect the computation of both basic and diluted (loss) earnings per share during periods of net (loss) earnings.
 
 
23
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
Notes to Consolidated Financial Statements (unaudited)
September 30, 2019
 
10.  SHAREHOLDERS’ EQUITY
 
On February 28, 2014, the Company’s Registration Statement on Form S-1, as amended, relating to the initial public offering of the Company’s units was declared effective by the SEC. The Registration Statement covered the offer and sale by the Company of 4,884,650 units, each consisting of one ordinary share and one warrant (“Unit”), which were sold to the public on March 26, 2014 at a price of $6.00 per Unit. The ordinary shares and warrants comprising the Units began separate trading on May 9, 2014. The ordinary shares and warrants are traded on the Nasdaq Capital Market under the symbols “OXBR” and “OXBRW,” respectively. One warrant may be exercised to acquire one ordinary share at an exercise price equal to $7.50 per share on or before March 26, 2024, as amended. At any time after September 26, 2014 and before the expiration of the warrants, the Company at its option may cancel the warrants in whole or in part, provided that the closing price per ordinary share has exceeded $9.38 for at least ten trading days within any period of twenty consecutive trading days, including the last trading day of the period.
 
The initial public offering resulted in aggregate gross proceeds to the Company of approximately $29.3 million (of which approximately $5 million related to the fair value proceeds on the warrants issued) and net proceeds of approximately $26.9 million after deducting underwriting commissions and offering expenses.
 
There were 8,230,700 warrants outstanding at September 30, 2019 and 2018. No warrants were exercised during the three and nine-month periods ended September 30, 2019 and 2018.
 
As of September 30, 2019, none of the Company’s retained earnings were restricted from payment of dividends to the company’s shareholders. However, since most of the Company’s capital and retained earnings may be invested in its subsidiaries, a dividend from the subsidiaries would likely be required in order to fund a dividend to the Company’s shareholders and would require notification to the Cayman Islands Monetary Authority (“CIMA”).
 
Under Cayman Islands law, the use of additional paid-in capital is restricted, and the Company will not be allowed to pay dividends out of additional paid-in capital if such payments result in breaches of the prescribed and minimum capital requirement. See also Note 12.
 
 
24
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
Notes to Consolidated Financial Statements (unaudited)
September 30, 2019
 
11. SHARE-BASED COMPENSATION
 
The Company currently has outstanding stock-based awards granted under the 2014 Omnibus Incentive Plan (the “Plan”). Under the Plan, the Company has discretion to grant equity and cash incentive awards to eligible individuals, including the issuance of up to 1,000,000 of the Company’s ordinary shares. At September 30, 2019, there were 400,000 shares available for grant under the Plan.
 
Stock options
 
The Company accounts for share-based compensation under the fair value recognition provisions of ASC Topic 718 – “Compensation – Stock Compensation.” Stock options granted and outstanding under the Plan vests quarterly over four years and are exercisable over the contractual term of ten years.
 
A summary of the stock option activity for the three and nine-month periods ended September 30, 2019 and 2018 is as follows:
 
 
 
Number
of
Options
 
 
Weighted-
Average
Exercise
Price
 
Weighted-
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic
Value
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding at January 1, 2019
  250,000 
 
 
 
 
 
 
 
Granted
  290,000 
 $2.00 
 
 
 
 
Outstanding at March 31, 2019
  540,000 
 $3.86 
 8.1 years
 $- 
Outstanding at June 30, 2019
  540,000 
 $3.86 
 7.9 years
 $- 
Outstanding at September 30, 2019
  540,000 
 $3.86 
 7.6 years
 $- 
Exercisable at September 30, 2019
  291,250 
 $5.26 
 6.3 years
 $- 
 
    
    
 
    
 
    
    
 
    
Outstanding at January 1, 2018
  250,000 
 $6.01 
 
    
Outstanding at March 31, 2018
  250,000 
 $6.01 
 7.2 years
 $- 
Outstanding at June 30, 2018
  250,000 
 $6.01 
 6.9 years
 $- 
Outstanding at September 30, 2018
  250,000 
 $6.01 
 6.7 years
 $- 
Exercisable at September 30, 2018
  208,125 
 $6.01 
 6.7 years
 $- 
 
Compensation expense recognized for the three-month periods ended September 30, 2019 and 2018 totaled $9,000 and for the nine-month periods ended September 30, 2019 and 2018, totaled $27,000 and $29,000 respectively. Compensation expense is included in general and administrative expenses. At September 30, 2019 and 2018, there was approximately $95,000 and $25,000, respectively, of total unrecognized compensation expense related to non-vested stock options granted under the Plan. The Company expects to recognize the remaining compensation expense over a weighted-average period of thirty-three (33) months.
 
 
25
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
Notes to Consolidated Financial Statements (unaudited)
September 30, 2019
 
11.  SHARE-BASED COMPENSATION (continued)
 
There were no options granted during the three and nine-month period ended September 30, 2018 and during the three months ended September 30, 2019. During the nine-month period ended September 30, 2019 the Company granted 290,000 options with fair value estimated on the date of grant using the following assumptions and the Black-Scholes option pricing model:
 
 
 
2019
 
 
 
 
 
Expected dividend yield
  0%
Expected volatility
  31%
Risk-free interest rate
  3%
Expected life (in years)
  10 
Per share grant date fair value of options issued
 $0.36 
 
At the time of the grant, the dividend yield was based on the Company’s history and expectation of dividend payouts at the time of the grant; expected volatility was based on volatility of similar companies’ common stock as described in Note 1; the risk-free rate was based on the U.S. Treasury yield curve in effect and the expected life was based on the contractual life of the options.
 
Restricted Stock Awards
 
The Company has granted and may grant restricted stock awards to eligible individuals in connection with their service to the Company. The terms of the Company’s outstanding restricted stock grants may include service, performance and market-based conditions. The fair value of any awards with market-based conditions is determined using a Monte Carlo simulation method, which calculates many potential outcomes for an award and then establishes fair value based on the most likely outcome. The determination of fair value with respect to the awards with only performance or service-based conditions is based on the value of the Company’s stock on the grant date.
 
During the three and nine-month periods ended September 30, 2019 and 2018, the Company did not grant any restricted stock. At September 30, 2019, there were no unvested restricted stock.
 
Compensation expense recognized for the three-month periods ended September 30, 2019 and 2018 totaled $0 and $22,000 respectively, and for the nine-month periods ended September 30, 2019 and 2018 totaled $0 and $65,000 respectively. Compensation expense is included in general and administrative expenses. At September 30, 2019 and 2018, there was approximately $0 and $22,000, respectively, of total unrecognized compensation expense related to non-vested restricted stock granted under the Plan.
 
 
 
26
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
Notes to Consolidated Financial Statements (unaudited)
September 30, 2019
 
12.  NET WORTH FOR REGULATORY PURPOSES
 
The subsidiaries are subject to a minimum and prescribed capital requirement as established by CIMA. Under the terms of their respective licenses, Oxbridge Reinsurance Limited and Oxbridge Re NS are required to maintain a minimum and prescribed capital requirement of $500 in accordance with the relevant subsidiary’s approved business plan filed with CIMA.
 
At September 30, 2019, the Oxbridge Reinsurance Limited’s net worth of $1.5 million exceeded the minimum and prescribed capital requirement. For the three and nine-month periods ended September 30, 2019, the Subsidiary’s net loss was approximately $159 thousand and $754 thousand respectively.
 
At September 30, 2019, the Oxbridge Re NS’ net worth of $79 thousand exceeded the minimum and prescribed capital requirement. For the three and nine-month periods ended September 30, 2019, the Subsidiary’s net income was approximately $30 thousand and $61 thousand respectively.
 
The Subsidiaries are not required to prepare separate statutory financial statements for filing with CIMA, and there were no material differences between the Subsidiaries' GAAP capital, surplus and net income, and its statutory capital, surplus and net income as of September 30, 2019 or for the period then ended.
 
13. FAIR VALUE AND CERTAIN RISKS AND UNCERTAINTIES
 
Fair values
 
With the exception of balances in respect of insurance contracts (which are specifically excluded from fair value disclosures under GAAP) and investment securities and derivative instruments as disclosed in Note 4 and 5 of these consolidated financial statements, the carrying amounts of all other financial instruments, which consist of cash and cash equivalents, restricted cash and cash equivalents, accrued interest and dividends receivable, premiums receivable and other assets and accounts payable and other liabilities, approximate their fair values due to their short-term nature.
 
Concentration of underwriting risk
 
As the Company’s current reinsurance business ultimately relates to the risks of a limited number of entities, the Company’s underwriting risks are not significantly diversified.
 
Concentrations of Credit and Counterparty Risk
 
The Company’s derivative instruments are subject to counterparty risk. The Company routinely monitor this risk.
 
 
27
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
Notes to Consolidated Financial Statements (unaudited)
September 30, 2019
 
13. FAIR VALUE AND CERTAIN RISKS AND UNCERTAINTIES (cont’d)
 
The Company may market retrocessional and reinsurance policies worldwide through its brokers.  Credit risk exists to the extent that any of these brokers may be unable to fulfill their contractual obligations to the Company.  For example, the Company is required to pay amounts owed on claims under policies to brokers, and these brokers, in the Company. In some jurisdictions, if a broker fails to make such a payment, the Company might remain liable to the ceding company for the deficiency. In addition, in certain jurisdictions, when the ceding company pays premiums for these policies to brokers, these premiums are considered to have been paid and the ceding insurer is no longer liable to the Company for those amounts, whether or not the premiums have actually been received.
 
The Company remains liable for losses it incurs to the extent that any third-party reinsurer is unable or unwilling to make timely payments under reinsurance agreements.  The Company would also be liable in the event that its ceding companies were unable to collect amounts due from underlying third-party reinsurers.
 
The Company mitigates its concentrations of credit and counterparty risk by using reputable and several counterparties which decreases the likelihood of any significant concentration of credit risk with any one counterparty. Additionally, the Company invests in fixed maturity securities that are investment grade or higher.
 
Market risk
 
Market risk exists to the extent that the values of the Company’s monetary assets fluctuate as a result of changes in market prices. Changes in market prices can arise from factors specific to individual securities or their respective issuers, or factors affecting all securities traded in a particular market. Relevant factors for the Company are both volatility and liquidity of specific securities and markets in which the Company holds investments. The Company has established investment guidelines that seek to mitigate significant exposure to market risk.
 
 
28
 
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
Notes to Consolidated Financial Statements (unaudited)
September 30, 2019
 
14. LEASES
 
We adopted ASU 2016-02, Leases on January 1, 2019, which resulted in the recognition of operating leases on the consolidated balance sheet in 2019 and forward. See Note 2 – Significant Accounting Policies for more information on the adoption of the ASU. Right-of-use assets and lease liabilities are disclosed as line in the consolidated balance sheet. We determine if a contract contains a lease at inception and recognize operating lease right-of-use assets and operating lease liabilities based on the present value of the future minimum lease payments at the commencement date. As our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments. Lease agreements that have lease and non-lease components, are accounted for as a single lease component. Lease expense is recognized on a straight-line basis over the lease term.
 
The Company’s operating lease obligations are for the Company’s office facilities. Our lease have remaining lease terms of approximately 53 months, and include an option to extend the lease. Under the terms of the lease, the Company also has the right to terminate the lease after thirty-six (36) months upon giving appropriate notice in writing to the Lessor. The components of lease expense and other lease information as of and during the three and nine-month period ended September 30, 2019 are as follows:
 
 
 
For the 
Three-Month Period
 
 
For the 
Nine-Month Period
 
(in thousands)
 
Ended 
September 30, 2019
 
 
Ended
September 30, 2019
 
Operating Lease Cost (1)
 $22 
 $63 
 
    
    
Cash paid for amounts included in the measurement of lease liabilities
    
    
Operating cash flows from operating leases
 $22 
 $71 
 
    
    
(1) Includes short-term leases
    
    
 
(in thousands)
 
At September 30,
2019
 
Operating lease right-of-use assets
 $140 
 
    
Operating lease liabilities
 $140 
 
    
Weighted-average remaining lease term - operating leases
  
4.42 years
 
 
    
Weighted-average discount rate - operating leases
  6.5%
 
 
29
 
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
Notes to Consolidated Financial Statements (unaudited)
September 30, 2019
 
14. LEASES (continued)
 
Future minimum lease payments under non-cancellable leases as of September 30, 2019, reconciled to our discounted operating lease liability presented on the consolidated balance sheet are as follows:
 
(in thousands)
 
At September 30,
2019
 
 
At December 31,
2018
 
Remainder of 2019
 $9 
 $- 
2020
  36 
  - 
2021
  36 
  - 
2022
  37 
  - 
2023
  37 
  - 
Thereafter
  6 
  - 
Total future minimum lease payments
 $161 
 $- 
 
    
    
Less imputed interest
  (21)
  N/A 
Total operating lease liability
 $140 
  N/A 
 
15. RELATED PARTY TRANSACTIONS
 
The Company had entered into reinsurance agreements with Claddaugh, which is a related entity through common directorships. At September 30, 2019 and December 31, 2018, there were no related-party amounts included within loss experience refund payable and unearned premium reserve on the consolidated balance sheets.
 
During the three and nine-month periods ended September 30, 2019 and 2018, included within change in loss experience refund payable and change in unearned premiums reserve on the consolidated statements of operations are the following related-party amounts:
 
 
 
Three Months Ended
 
 
Nine Months Ended
 
 
 
September 30,
 
 
September 30,
 
 
 
2019
 
 
2018
 
 
2019
 
 
2018
 
 
 
(in thousands)
 
 
(in thousands) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue
 
 
 
 
 
 
 
 
 
 
 
 
Assumed premiums
  - 
  - 
  - 
  - 
Change in loss experience refund payable
  - 
  - 
  - 
  (225)
Change in unearned premiums reserve
  - 
  - 
  - 
 592 
 
During the nine-month period ending September 30, 2019, Mr. Jay Madhu, a director and officer of the Company and its subsidiaries invested $50 thousand in Series 2019-1 participating notes.
 
16. SUBSEQUENT EVENTS
 
We evaluate all subsequent events and transactions for potential recognition or disclosure in our consolidated financial statements. There were no other events subsequent to September 30, 2019 for which disclosure was required.
 
 
30
 
 
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
 
SPECIAL NOTE ABOUT FORWARD-LOOKING STATEMENTS
 
Certain statements in this Quarterly Report on Form 10-Q, including in this Management’s Discussion and Analysis, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking statements generally are identified by the words “believe,” “project,” “predict,” “expect,” “anticipate,” “estimate,” “intend,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. A detailed discussion of risks and uncertainties that could cause actual results and events to differ materially from such forward-looking statements is included in the section entitled “Risk Factors” contained in our Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 19, 2019. We undertake no obligation to publicly update or revise any forward -looking statements, whether as a result of new information, future events, or otherwise. Readers are cautioned not to place undue reliance on the forward -looking statements which speak only to the dates on which they were made.
 
GENERAL
 
The following is a discussion and analysis of our results of operations for the three and nine-month periods ended September 30, 2019 and 2018 and our financial condition as of September 30, 2019 and December 31, 2018. The following discussion should be read in conjunction with our consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q and in our Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 19, 2019. References to “we,” “us,” “our,” “our company,” or “the Company” refer to Oxbridge Re Holdings Limited and its wholly-owned subsidiaries, Oxbridge Reinsurance Limited and Oxbridge Re NS, unless the context dictates otherwise.
 
 
31
 
 
Overview
 
We are a Cayman Islands specialty property and casualty reinsurer that provides reinsurance solutions through our reinsurance subsidiary, Oxbridge Reinsurance Limited and Oxbridge Re NS, which functions as a reinsurance sidecar which increases the underwriting capacity of Oxbridge Reinsurance Limited. Oxbridge Re NS commenced operations on June 1, 2018 and issued participating notes to third party investors, the proceeds of which was utilized to collateralize Oxbridge Reinsurance Limited’s reinsurance obligations. We focus on underwriting fully-collateralized reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. We specialize in underwriting medium frequency, high severity risks, where we believe sufficient data exists to analyze effectively the risk/return profile of reinsurance contracts.
 
We underwrite reinsurance contracts on a selective and opportunistic basis as opportunities arise based on our goal of achieving favorable long-term returns on equity for our shareholders. Our goal is to achieve long-term growth in book value per share by writing business that generates attractive underwriting profits relative to the risk we bear. Unlike other insurance and reinsurance companies, we do not intend to pursue an aggressive investment strategy and instead will focus our business on underwriting profits rather than investment profits. However, we intend to complement our underwriting profits with investment profits on an opportunistic basis. Our primary business focus is on fully collateralized reinsurance contracts for property catastrophes, primarily in the Gulf Coast region of the United States, with an emphasis on Florida. Within that market and risk category, we attempt to select the most economically attractive opportunities across a variety of property and casualty insurers. As our capital base grows, however, we expect that we will consider further growth opportunities in other geographic areas and risk categories.
 
Our level of profitability is primarily determined by how adequately our premiums assumed and investment income cover our costs and expenses, which consist primarily of acquisition costs and other underwriting expenses, claim payments and general and administrative expenses. One factor leading to variation in our operational results is the timing and magnitude of any follow-on offerings we undertake (if any), as we are able to deploy new capital to collateralize new reinsurance treaties and consequently, earn additional premium revenue. In addition, our results of operations may be seasonal in that hurricanes and other tropical storms typically occur during the period from June 1 through November 30. Further, our results of operations may be subject to significant variations due to factors affecting the property and casualty insurance industry in general, which include competition, legislation, regulation, general economic conditions, judicial trends, and fluctuations in interest rates and other changes in the investment environment.
 
Because we employ an opportunistic underwriting and investment philosophy, period-to-period comparisons of our underwriting results may not be meaningful. In addition, our historical investment results may not necessarily be indicative of future performance. Due to the nature of our reinsurance and investment strategies, our operating results will likely fluctuate from period to period.
 
 
32
 
 
Due to influx of new risk capital from alternative capital market participants such as hedge funds and pension funds, we believe that the reinsurance industry is currently over-capitalized and will continue in this trend for the foreseeable future. The over-capitalization of the market is not uniform as there are a number of insurers and reinsurers that have suffered and continue to suffer from capacity issues. We continue to assess the opportunities that may be available to us with insurance and reinsurance companies with this profile. If the reinsurance market continues to soften, our strategy is to reduce premium writings rather than accept mispriced risk and conserve our capital for a more opportune environment. Significant rate increases could occur if financial and credit markets experience adverse shocks that result in the loss of capital of insurers and reinsurers, or if there are major catastrophic events, especially in North America.
 
PRINCIPAL REVENUE AND EXPENSE ITEMS
 
Revenues
 
We derive our most significant revenues from two principal sources:
 
premiums assumed from reinsurance on property and casualty business; and
 
income from investments, including Industry Loss Warranties
 
Premiums assumed include all premiums received by a reinsurance company during a specified accounting period, even if the policy provides coverage beyond the end of the period. Premiums are earned over the term of the related policies. At the end of each accounting period, the portion of the premiums that are not yet earned are included in the unearned premiums reserve and are realized as revenue in subsequent periods over the remaining term of the policy. Our policies typically have a term of twelve months. Thus, for example, for a policy that is written on July 1, 2019, typically one-half of the premiums will be earned in 2019 and the other half will be earned during 2020. However, in the event of limit losses on our policies, premium recognition will be accelerated to match losses incurred in the period, when there is no possibility of any future treaty-year losses under the contracts.
 
Premiums from reinsurance on property and casualty business assumed are directly related to the number, type and pricing of contracts we write.
 
Premiums assumed are recorded net of change in loss experience refund, which consists of changes in amounts due to the cedants under one of our reinsurance contracts. These contracts contain retrospective provisions that adjust premiums in the event losses are minimal or zero. We recognize a liability pro-rata over the period in which the absence of loss experience obligates us to refund premiums under the contracts, and we will derecognize such liability in the period in which a loss experience arises. The change in loss experience refund is negatively correlated to loss and loss adjustment expenses described below.
 
Income from our investments is primarily comprised of interest income, dividends and net realized and unrealized gains (losses) on investment securities. Such income is primarily from the Company’s investments, which includes investments held in trust accounts that collateralize the reinsurance policies that we write. The investment parameters for trust accounts are generally be established by the cedant for the relevant policy.
 
 
33
 
 
Industry Loss Warranties 
The Company may buy and sell industry loss warranties as a way to access certain risks. An industry loss warranty is a financial instrument designed to protect insurers or reinsurers from severe losses due to natural and man-made catastrophes and can take the form of either an insurance contract or a swap agreement. Under both forms, a premium is paid at the inception of the contract and, in return, a payout is made if a catastrophic event causes loss to the insurance industry in excess of a predetermined trigger amount.
 
Industry loss warranties may also be triggered by other parametric measurements defined in the contract such as observed wind speeds, measured seismic activity or other factors. Industry loss warranties in the form of an insurance contract (also referred to as the "indemnity form") are typically dual-trigger instruments and, in addition to requiring a loss to the industry, require that the buyer of the protection actually suffer a loss from the triggering event. The Company may buy and sell industry loss warranties in the form of an insurance contract or in the form of a derivative contract.
 
Expenses
 
Our expenses consist primarily of the following:
 
losses and loss adjustment expenses;
 
policy acquisition costs and underwriting expenses; and
 
general and administrative expenses.
 
Loss and loss adjustment expenses are a function of the amount and type of reinsurance contracts we write and of the loss experience of the underlying coverage. As described below, loss and loss adjustment expenses are based on the claims reported by our Company’s ceding insurers, and may include an actuarial analysis of the estimated losses, including losses incurred during the period and changes in estimates from prior periods. Depending on the nature of the contract, loss and loss adjustment expenses may be paid over a period of years.
 
Policy acquisition costs and underwriting expenses consist primarily of brokerage fees, ceding commissions, premium taxes and other direct expenses that relate to our writing of reinsurance contracts. We amortize deferred acquisition costs over the related contract term.
 
General and administrative expenses consist of salaries and benefits and related costs, including costs associated with our professional fees, rent and other general operating expenses consistent with operating as a public company.
 
 
34
 
 
RESULTS OF OPERATIONS
 
The following is our consolidated statement of operations and performance ratios for the three and nine-month periods ended September 30, 2019 and 2018 (dollars in thousands, except per share amounts):
 
 
 
Three Months Ended
 
 
Nine Months Ended
 
 
 
 September 30,
 
 
 September 30,
 
 
 
2019
 
 
2018
 
 
2019
 
 
2018
 
 
 
(unaudited)
 
 
(unaudited)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue
 
 
 
 
 
 
 
 
 
 
 
 
Assumed premiums
 $- 
  47 
  1,116 
  2,627 
Change in loss experience refund payable
  - 
  - 
  - 
  (225)
Change in unearned premiums reserve
  279 
  653 
  (744)
  (1,148)
 
    
    
    
    
Net premiums earned
  279 
  700 
  372 
  1,254 
Net income from derivative instruments
  - 
  397 
  - 
  773 
Net investment and other income
  54 
  100 
  182 
  280 
        Net realized investment gains(losses)
  - 
  (61)
  3 
  (237)
        Change in fair value of equity securities
  17 
  118 
  20 
  22 
 
    
    
    
    
Total revenue
  350 
  1,254 
  577 
  2,092 
 
    
    
    
    
Expenses
    
    
    
    
Net loss on commutation
  - 
  - 
  - 
  8 
Policy acquisition costs and underwriting expenses
  31 
  63 
  41 
  101 
General and administrative expenses
  264 
  305 
  808 
  981 
 
    
    
    
    
Total expenses
  295 
  368 
  849 
  1,090 
 
    
    
    
    
Income (loss) before (income) attributable to Series 2019-1 noteholders
 $55 
  886 
  (272)
  1,002 
 
    
    
    
    
(Income) attributable to Series 2019-1 noteholders
  (70)
  (234)
  (94)
  (296)
 
    
    
    
    
Net (loss) income
 $(15)
  652 
  (366)
  706 
 
    
    
    
    
(Loss) Earnings per share
    
    
    
    
Basic and Diluted
 $(0.00)
  0.11 
  (0.06)
  0.12 
 
    
    
    
    
Dividends paid per share
 $- 
  - 
  - 
  - 
 
    
    
    
    
 
    
    
    
    
 
    
    
    
    
Performance ratios to net premiums earned:
    
    
    
    
Loss ratio
  0.0%
  0.0%
  0.0%
  0.0%
Acquisition cost ratio
  11.1%
  9.0%
  11.0%
  8.1%
Expense ratio
  105.7%
  33.5%
  228.2%
  53.8%
Combined ratio
  105.7%
  33.5%
  228.2%
  53.8%
 
General. Net loss for the quarter ended September 30, 2019 was $15 thousand, or ($0.00) per basic and diluted share, compared to a net income of $652 thousand, or $0.11 per basic and diluted share, for the quarter ended September 30, 2018. The decrease is due primarily to lower net premiums earned resulting from decreased capital deployed.
 
 
35
 
 
Net loss for the nine months ended September 30, 2019 was $366 thousand, or ($0.06) per basic and diluted share, compared to a net income of $706 thousand, or $0.12 per basic and diluted share, for the nine months ended September 30, 2018. The decrease is due primarily to lower net premiums earned resulting from decreased capital deployed.
 
Premium Income. Net premiums earned typically reflects the pro rata inclusion into income of premiums assumed (net of loss experience refund) over the life of the reinsurance contracts.
 
Net premiums earned for the quarter ended September 30, 2019 decreased $421 thousand, to $279 thousand from $700 thousand for the quarter ended September 30, 2018. The decrease is wholly due to the fact that lower capital was deployed in the current period, when compared to the same period in 2018.
 
Net premiums earned for the nine months ended September 30, 2019 decreased $882 thousand, to $372 thousand from $1,254 thousand for the nine months ended September 30, 2018. The decrease is wholly due to the fact that lower capital was deployed in the current period, when compared to the same period in 2018.
 
Losses Incurred. There were no losses incurred during the three and nine-month periods ending September 30, 2019 and 2018.
 
Policy Acquisition Costs and Underwriting Expenses. Acquisition costs represent the amortization of the brokerage fees and federal excise taxes incurred on reinsurance contracts placed. Policy acquisition costs and underwriting expenses for the quarter ended September 30, 2019 decreased $32 thousand to $31 thousand from $63 thousand for the quarter ended September 30, 2018. The decrease is due to the decrease in net premiums earned during the current quarter, when compared with prior year-ago period.
 
Policy acquisition costs and underwriting expenses for the nine-month period ended September 30, 2019 decreased $60 thousand to $41 thousand from $101 thousand for the nine-month period ended September 30, 2018. The decrease is due to the decrease in net premiums earned during the nine-month period, when compared with prior year-ago period.
 
General and Administrative Expenses. General and administrative expenses for the quarter ended September 30, 2019 decreased $41 thousand, to $264 thousand, from $305 thousand for the quarter ended September 30, 2018. The decrease is due to cost savings initiatives implemented by the Company.
 
General and administrative expenses for the nine-month period ended September 30, 2019 decreased $173 thousand, to $808 thousand, from $981 thousand for the nine-month period ended September 30, 2018. The decrease is due to cost savings initiatives implemented by the Company.
 
 
36
 
 
MEASUREMENT OF RESULTS
 
We use various measures to analyze the growth and profitability of business operations. For our reinsurance business, we measure growth in terms of premiums assumed and we measure underwriting profitability by examining our loss, underwriting expense and combined ratios. We analyze and measure profitability in terms of net income and return on average equity.
 
Premiums Assumed. We use gross premiums assumed to measure our sales of reinsurance products. Gross premiums assumed also correlates to our ability to generate net premiums earned.
 
Loss Ratio. The loss ratio is the ratio of losses and loss adjustment expenses incurred to premiums earned and measures the underwriting profitability of our reinsurance business. The loss ratio for the three and nine-month periods ended September 30, 2019 and September 30, 2018 was 0%. This is due to no loss and loss adjustment expenses incurred in the periods ended September 30, 2019 and 2018.
 
Acquisition Cost Ratio. The acquisition cost ratio is the ratio of policy acquisition costs and other underwriting expenses to net premiums earned. The acquisition cost ratio measures our operational efficiency in producing, underwriting and administering our reinsurance business. The acquisition cost ratio increased from 9% for the quarter ended September 30, 2018 to 11.1% for the quarter ended September 30, 2019. The increase is due to the overall higher weighted-average acquisition costs on reinsurance contracts in force during the three-month period ended September 30, 2019 compared with the three-month period ended September 30, 2018.
 
The acquisition cost ratio increased from 8.1% for the nine-month period ended September 30, 2018 to 11% for the nine-month period ended September 30, 2019. The increase is due to the overall higher weighted-average acquisition costs on reinsurance contracts in force during the nine-month period ended September 30, 2019 compared with the nine-month period ended September 30, 2018.
 
Expense Ratio. The expense ratio is the ratio of policy acquisition costs, other underwriting expenses and other administrative expenses to net premiums earned. In addition, the expense ratio includes any gain or loss resulting from deposit accounted contracts as well as any amortized cost of weather derivative swaps entered into as part of our underwriting activities. We use the expense ratio to measure our operating performance. The expense ratio increased from 33.5% for the three-month period ended September 30, 2018 to 105.7% for the three-month period ended September 30, 2019. The increase is due primarily to a lower denominator in net premiums earned and net income from derivative instruments as recorded during the three-month period ended September 30, 2019, when compared with the three-month period ended September 30, 2018.
 
The expense ratio increased from 53.8% for the nine-month period ended September 30, 2018 to 228.2% for the nine-month period ended September 30, 2019. The increase is due primarily to a lower denominator in net premiums earned and net income from derivative instruments as recorded during the nine-month period ended September 30, 2019, when compared with the nine-month period ended September 30, 2018.
 
 
37
 
 
Combined Ratio. We use the combined ratio to measure our underwriting performance. The combined ratio is the sum of the loss ratio and the expense ratio. If the combined ratio is at or above 100%, we are not underwriting profitably and may not be profitable. The combined ratio increased from 33.5% for the three-month period ended September 30, 2018 to 105.7% for the three-month period ended September 30, 2019. The increase in the combined ratio is wholly due to a lower denominator in net premiums earned and net income from derivative instruments as recorded during the three-month period ended September 30, 2019, when compared with the three-month period ended September 30, 2018.
 
The combined ratio increased from 53.8% for the nine-month period ended September 30, 2018 to 228.2% for the nine-month period ended September 30, 2019. The increase in the combined ratio is wholly due to a lower denominator in net premiums earned and net income from derivative instruments as recorded during the nine-month period ended September 30, 2019, when compared with the nine-month period ended September 30, 2018.
 
FINANCIAL CONDITION – SEPTEMBER 30, 2019 COMPARED TO DECEMBER 31, 2018
 
Restricted Cash and Cash Equivalents. As of September 30, 2019, our restricted cash and cash equivalents decreased by $1.3 million, or 41%, to $1.9 million, from $3.2 million as of December 31, 2018. The decrease is the net result of the withdrawal by the counterparty of our ILW Swap for settlement of losses as well as collateral deposits made during the nine months ended September 30, 2019.
 
Investments. As of September 30, 2019, our total investments decreased by $571 thousand or 49% to $584 thousand, from $1.2 million as of December 31, 2018. The decrease is primarily a result of net sales of fixed-maturity securities during the nine-month period ended September 30, 2019.
 
Reserve for Losses and Loss Adjustment Expenses. As of September 30, 2019, our reserve for losses and loss adjustment expenses decreased by $4 million, or 97%, to $107 thousand, from $4.1 million at December 31, 2018. The decrease is wholly due to the settlement of losses on weather-related events occurring in previous quarters for which the Company had set up appropriate reserves.
 
Notes Payable. As of September 30, 2019, our notes payable increased to $600 thousand, from $Nil at December 31, 2018. The increase is wholly due to the issuance of Series 2019-1 participating notes by our reinsurance sidecar subsidiary, Oxbridge Re NS during the nine months ending September 30, 2019.
 
 
38
 
 
LIQUIDITY AND CAPITAL RESOURCES
 
General
 
We are organized as a holding company with substantially no operations at the holding company level. Our operations are conducted through our reinsurance subsidiaries, Oxbridge Reinsurance Limited and Oxbridge Re NS, which underwrites risks associated with our property and casualty reinsurance programs. We have minimal continuing cash needs at the holding company level, with such needs principally being related to the payment of administrative expenses and shareholder dividends. There are restrictions on Oxbridge Reinsurance Limited’s and Oxbridge Re NS’ ability to pay dividends which are described in more detail below.
 
Sources and Uses of Funds
 
Our sources of funds primarily consist of premium receipts (net of brokerage fees and federal excise taxes, where applicable) and investment income, including interest, dividends and realized gains. We use cash to pay losses and loss adjustment expenses, other underwriting expenses, dividends, and general and administrative expenses. Substantially all of our surplus funds, net of funds required for cash liquidity purposes, are invested in accordance with our investment guidelines. Our investment portfolio is primarily comprised of cash and highly liquid securities, which can be liquidated, if necessary, to meet current liabilities. Should it become necessary, we believe that we will have sufficient flexibility to liquidate any long-term securities that we may own in a rising market to generate liquidity.
 
As of September 30, 2019, we believe we had sufficient cash flows from operations to meet our liquidity requirements. We expect that our operational needs for liquidity will be met by cash, investment income and funds generated from underwriting activities. During the nine-month period ending September 30, 2019, we issued participating notes through our reinsurance sidecar subsidiary, Oxbridge Re NS. We have no current plans to issue further debt, other than through additional participating notes and we expect to fund our operations for the foreseeable future from operating cash flows, as well as from potential future equity offerings. However, we cannot provide assurances that in the future we will not incur indebtedness to implement our business strategy, pay claims or make acquisitions.
 
Although Oxbridge Re Holdings Limited is not subject to any significant legal prohibitions on the payment of dividends, its subsidiaries Oxbridge Reinsurance Limited and Oxbridge Re NS are subject to Cayman Islands regulatory constraints that affect its ability to pay dividends to us and include a minimum net worth requirement. Currently, the minimum net worth requirement for each subsidiary is $500. As of September 30, 2019, each subsidiary exceeded the minimum required. By law, each subsidiary is restricted from paying a dividend if such a dividend would cause its net worth to drop to less than the required minimum.
 
Our reinsurance operations exposed us to claims arising out of unpredictable catastrophic events during the fourth quarter of 2018. The incidence and severity of catastrophes are inherently unpredictable, but the loss experience of property catastrophe reinsurers has been generally characterized as low frequency and high severity. Claims from catastrophic events have reduced our earnings and caused substantial volatility in our results of operations, and adversely affected our financial condition. The corresponding reduction in our surplus level will impact our ability to write new reinsurance policies at future renewal periods.
 
 
39
 
 
Cash Flows
 
Our cash flows from operating, investing and financing activities for the nine-month periods ended September 30, 2019 and 2018 are summarized below.
 
Cash Flows for the Nine months ended September 30, 2019 (in thousands)
 
Net cash used in operating activities for the nine months ended September 30, 2019 totaled $4,439, which consisted primarily of cash received from net premiums written less cash disbursed for operating expenses and net loss payments. Net cash provided by investing activities of $592 was primarily due to the net proceeds from sale of fixed-maturity securities. Net cash provided by financing activities totaled $600, which consisted of proceeds on issuance of Series 2019-1 participating notes.
 
Cash Flows for the Nine months ended September 30, 2018 (in thousands)
 
Net cash used in operating activities for the nine months ended September 30, 2018 totaled $2,214, which consisted primarily of cash received from net written premiums less cash disbursed for operating expenses and net loss payments. Net cash provided by investing activities of $1,475 was primarily due to the net proceeds from sale of equity available-for-sale securities. Net cash provided by financing activities totaled $2,000 representing net proceeds on issuance of Series 2018-1 participating notes.
 
OFF-BALANCE SHEET ARRANGEMENTS
 
As of September 30, 2019, we had no off-balance sheet arrangements as defined in Item 303(a)(4) of Regulation S-K.
 
EXPOSURE TO CATASTROPHES
 
As with other reinsurers, our operating results and financial condition could be adversely affected by volatile and unpredictable natural and man-made disasters, such as hurricanes, windstorms, earthquakes, floods, fires, riots and explosions. Although we attempt to limit our exposure to levels we believe are acceptable, it is possible that an actual catastrophic event or multiple catastrophic events could have a material adverse effect on our financial condition, results of operations and cash flows. As described under “CRITICAL ACCOUNTING POLICIES—Reserves for Losses and Loss Adjustment Expenses” below, under GAAP, we are not permitted to establish loss reserves with respect to losses that may be incurred under reinsurance contracts until the occurrence of an event which may give rise to a claim. As a result, only loss reserves applicable to losses incurred up to the reporting date may be established, with no provision for a contingency reserve to account for expected future losses.
  
 
40
 
 
CRITICAL ACCOUNTING POLICIES
 
We are required to make estimates and assumptions in certain circumstances that affect amounts reported in our consolidated financial statements and related footnotes. We evaluate these estimates and assumptions on an on-going basis based on historical developments, market conditions, industry trends and other information that we believe to be reasonable under the circumstances. These accounting policies pertain to premium revenues and risk transfer, reserve for loss and loss adjustment expenses and the reporting of deferred acquisition costs.
 
Premium Revenue and Risk Transfer. We record premiums revenue as earned pro-rata over the terms of the reinsurance agreements, or period of risk, where applicable, and the unearned portion at the balance sheet date is recorded as unearned premiums reserve. A reserve is made for estimated premium deficiencies to the extent that estimated losses and loss adjustment expenses exceed related unearned premiums. Investment income is not considered in determining whether or not a deficiency exists.
 
We account for reinsurance contracts in accordance with ASC 944, ‘‘Financial Services – Insurance.” Assessing whether or not a reinsurance contract meets the conditions for risk transfer requires judgment. The determination of risk transfer is critical to reporting premiums written. If we determine that a reinsurance contract does not transfer sufficient risk, we must account for the contract as a deposit liability.
 
Loss Experience Refund Payable. Certain contracts may include retrospective provisions that adjust premiums or result in profit commissions in the event losses are minimal or zero. Under such contracts, the Company expects to recognize aggregate liabilities payable to the ceding insurers assuming no losses occur during the contract period. In accordance with GAAP, the Company will recognize a liability in the period in which the absence of loss experience obligates the Company to pay cash or other consideration under the contract. On the contrary, the Company will derecognize such liability in the period in which a loss experience arises. Such adjustments to the liability, which accrue throughout the contract term, will reduce the liability should a catastrophic loss event covered by the Company occur.
 
Reserves for Losses and Loss Adjustment Expenses. We determine our reserves for losses and loss adjustment expenses on the basis of the claims reported by our ceding insurers and for losses incurred but not reported, we utilize the assistance of an independent actuary. The reserves for losses and loss adjustment expenses represent management’s best estimate of the ultimate settlement costs of all losses and loss adjustment expenses. We believe that the amounts are adequate; however, the inherent impossibility of predicting future events with precision, results in uncertainty as to the amount which will ultimately be required for the settlement of losses and loss expenses, and the differences could be material. Adjustments are reflected in the consolidated statements of operations in the period in which they are determined.
 
Under GAAP, we are not permitted to establish loss reserves until the occurrence of an actual loss event. As a result, only loss reserves applicable to losses incurred up to the reporting date may be recorded, with no allowance for the provision of a contingency reserve to account for expected future losses. Losses arising from future events, which could be substantial, are estimated and recognized at the time the loss is incurred.
 
 
 
41
 
 
As of September 30, 2019, our best estimate for reserves for loss and loss adjustment expenses was $107,000, with IBNR representing approximately 70% of such reserves.
 
Our reserving methodology does not lend itself well to a statistical calculation of a range of estimates surrounding the best point estimate of our reserve for loss and loss adjustment expense. Due to the low frequency and high severity nature of claims within much of our business, our reserving methodology principally involves arriving at a specific point estimate for the ultimate expected loss on a contract by contract basis, and our aggregate loss reserves are the sum of the individual loss reserves established.
 
 
Deferred Acquisition Costs. We defer certain expenses that are directly related to and vary with producing reinsurance business, including brokerage fees on gross premiums assumed, premium taxes and certain other costs related to the acquisition of reinsurance contracts. These costs are capitalized and the resulting asset, deferred acquisition costs, is amortized and charged to expense in future periods as premiums assumed are earned. The method followed in computing deferred acquisition costs limits the amount of such deferral to its estimated realizable value. The ultimate recoverability of deferred acquisition costs is dependent on the continued profitability of our reinsurance underwriting. If our underwriting ceases to be profitable, we may have to write off a portion of our deferred acquisition costs, resulting in a further charge to income in the period in which the underwriting losses are recognized.
 
Stock-Based Compensation: The Company accounts for stock-based compensation under the fair value recognition provisions of GAAP which requires the measurement and recognition of compensation for all stock-based awards made to employees and directors, including stock options, warrants and restricted stock issuances based on estimated fair values. The Company measures compensation for restricted stock based on the price of the Company’s ordinary shares at the grant date. Determining the fair value of share purchase options at the grant date requires significant estimation and judgment. The Company uses an option-pricing model (Black-Scholes option pricing model) to assist in the calculation of fair value for share purchase options. The Company's shares have not been publicly traded for a sufficient length of time to solely use the Company's performance to reasonably estimate the expected volatility.
 
Therefore, when estimating the expected volatility, the Company takes into consideration the historical volatility of similar entities. The Company considers factors such as an entity's industry, stage of life cycle, size and financial leverage when selecting similar entities. The Company uses a sample peer group of companies in the reinsurance industry as well as the Company’s own historical volatility in determining the expected volatility. Additionally, the Company uses the full life of the options, ten years, as the estimated term of the options, and has assumed no forfeitures during the life of the options.
 
The Company uses the straight-line attribution method for all grants that include only a service condition. Compensation expense related to all awards is included in general and administrative expenses. 
 
 
42
 
 
JOBS ACT
 
The JOBS Act contains provisions that, among other things, reduce certain reporting requirements for an emerging growth company.  We have determined that, as an emerging growth company, we will not: (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404(b); (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act; (iii) comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements; (iv) disclose certain executive compensation-related items such as the correlation between executive compensation and performance and comparisons of our Chief Executive Officer’s compensation to median employee compensation; or (v) comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies.
 
We will continue to be an emerging growth company until the earliest of: (i) the last day of the fiscal year during which we had total annual gross revenues of at least $1 billion (as indexed for inflation); (ii) the last day of the fiscal year following the fifth anniversary of the date of our initial public offering; (iii) the date on which we have, during the previous three-year period, issued more than $1.0 billion in non-convertible debt; and (iv) the date on which we are deemed to be a “large accelerated filer,” as defined under the Exchange Act.
 
 
Item 3. 
Quantitative and Qualitative Disclosures About Market Risk
 
Because we are a smaller reporting company, we are not required to provide this information.
 
Item 4. 
Controls and Procedures
 
Evaluation of Disclosure Controls and Procedures
 
Under the supervision and with the participation of our Chief Executive Officer (our principal executive officer) and our Chief Financial Officer (our principal financial officer), we have evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report. Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report.
 
Changes in Internal Control Over Financial Reporting
 
There have been no changes in our internal control over financial reporting that occurred during the quarter ended September 30, 2019 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
 
 
43
 
 
PART II – OTHER INFORMATION
 
Item 1. 
Legal Proceedings
 
We are not currently involved in any litigation or arbitration. We anticipate that, similar to the rest of the insurance and reinsurance industry, we will be subject to litigation and arbitration in the ordinary course of business.
 
Item 1A.
Risk Factors
 
There have been no material changes to the risk factors previously disclosed in the section entitled “Risk Factors” in our Form 10-K, which was filed with the Securities and Exchange Commission on March 19, 2019.
 
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
 
(a)
Sales of Unregistered Securities
 
None.
 
(b)
Repurchases of Equity Securities
 
None.
 
(c)
Use of Proceeds
 
None.
 
Item 3. 
Defaults Upon Senior Securities
 
None.
 
Item 4. 
Mine Safety Disclosures
 
Not applicable.
 
Item 5. 
Other Information
 
None.
 
Item 6. 
Exhibits
 
The following exhibits are filed herewith:
 
Exhibit No.
 
Document
 
 
 
 
Certifications of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act and Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934.
 
 
 
 
Certifications of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act and Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934.
 
 
 
 
Written Statement of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. §1350.
 
 
 
101
 
The following materials from Oxbridge Re Holdings Limited’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 are filed herewith, formatted in XBRL (Extensible Business Reporting Language): (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations, (iii) the Consolidated Statements of Comprehensive Income, (iv) the Consolidated Statements of Cash Flows, (v) the Consolidated Statements of Changes in Shareholders’ Equity and (vi) the Notes to Consolidated Financial Statements.
 
 
44
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
OXBRIDGE RE HOLDINGS LIMITED
 
 
 
 
 
Date: November 4, 2019
By:  
/s/ JAY MADHU     
 
 
 
Jay Madhu 
 
 
 
Chief Executive Officer and President
(Principal Executive Officer)
 
 
 
 
Date: November 4, 2019
By:  
/s/ WRENDON TIMOTHY
 
 
 
Wrendon Timothy 
 
 
 
Chief Financial Officer and Secretary
(Principal Financial Officer and Principal Accounting Officer) 
 
 
 
 

 
 
 
 

 
 
45
Blueprint
  Exhibit 31.1

Certifications of the Chief Executive Officer
Pursuant to Section 302 of the Sarbanes-Oxley Act and
Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934
 
I, Jay Madhu, certify that:
 
1.           I have reviewed this Quarterly Report on Form 10-Q of Oxbridge Re Holdings Limited;
 
2.           Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.           Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.           The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
(a)           Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
(b)           Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
(c)           Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
(d)           Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5.           The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
(a)           All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
(b)           Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
Date: November 4, 2019
 

By:  
/s/ JAY MADHU
 
 
 
Jay Madhu 
 
 
 
Chief Executive Officer and President  
(Principal Executive Officer)
 
 
 
Blueprint
  Exhibit 31.2

4Certifications of the Chief Financial Officer
Pursuant to Section 302 of the Sarbanes-Oxley Act and
Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934
 
I, Wrendon Timothy, certify that:
 
1.           I have reviewed this Quarterly Report on Form 10-Q of Oxbridge Re Holdings Limited;
 
2.           Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.           Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.           The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
(a)           Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
(b)           Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
(c)           Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
(d)           Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5.           The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
(a)           All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
(b)           Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
Date: November 4, 2019
 

By:  
/s/ WRENDON TIMOTHY
 
 
 
Wrendon Timothy 
 
 
 
Chief Financial Officer and Secretary (Principal Financial Officer and Principal Accounting Officer)
 
 
 
Blueprint
  Exhibit 32

Written Statement of the Chief Executive Officer and Chief Financial Officer
Pursuant to 18 U.S.C. §1350
 
Solely for the purposes of complying with 18 U.S.C. §1350, we, the undersigned Chief Executive Officer and Chief Financial Officer of Oxbridge Re Holdings Limited (the “Company”), hereby certify, based on our knowledge, that the Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2019 (the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
/s/ JAY MADHU      
Jay Madhu
Chief Executive Officer and President
(Principal Executive Officer)
 
 
/s/ WRENDON TIMOTHY      
Wrendon Timothy
Chief Financial Officer and Secretary
 
(Principal Financial Officer and Principal
 
Accounting Officer)
 
Date: November 4, 2019
 
 
v3.19.3
Related Party Transactions (Tables)
9 Months Ended
Sep. 30, 2019
Related Party Transactions [Abstract]  
Summary of related party transactions
    Three Months Ended     Nine Months Ended  
    September 30,     September 30,  
    2019     2018     2019     2018  
    (in thousands)     (in thousands)   
                         
Revenue                        
Assumed premiums     -       -       -       -  
Change in loss experience refund payable     -       -       -       (225 )
Change in unearned premiums reserve     -       -       -       592  
v3.19.3
Investments (Details) - US Treasury and Government
$ in Thousands
Dec. 31, 2018
USD ($)
Cost or amortized cost, total available-for-sale securities $ 991
Gross unrealized gain, total available-for-sale securities 2
Gross unrealized loss, total available-for-sale securities 0
Estimated fair value, total available-for-sale securities $ 993
v3.19.3
Reserve for Losses and Loss Adjustment Expenses (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Insurance [Abstract]        
Balance, beginning of period $ 107 $ 167 $ 4,108 $ 4,836
Incurred related to: current period 0 0 0 0
Incurred related to: prior period 0 0 0 (1,012)
Total incurred 0 0 0 (1,012)
Paid related to: current period 0 0 0 0
Paid related to: prior period 0 0 (4,001) (3,657)
Total paid 0 0 (4,001) (3,657)
Balance, end of period 107 167 107 167
Add: reinsurance recoverable 0 0 0 0
Gross balance, end of period $ 107 $ 167 $ 107 $ 167
v3.19.3
(Loss) Earnings Per Share
9 Months Ended
Sep. 30, 2019
Earnings Per Share [Abstract]  
(Loss) Earnings Per Share

A summary of the numerator and denominator of the basic and diluted (loss) earnings per share is presented below (dollars in thousands except per share amounts):

 

    Three Months Ended     Nine Months Ended  
     September 30,      September 30,  
    2019     2018     2019     2018  
                         
Numerator:                        
     Net (loss) earnings   $ (15 )     652     $ (366 )     706  
                                 
Denominator:                                
    Weighted average shares - basic     5,733,587       5,733,587       5,733,587       5,733,587  
    Effect of dilutive securities - Stock options     -       -       -       -  
    Shares issuable upon conversion of warrants     -       -       -       -  
    Weighted average shares - diluted     5,733,587       5,733,587       5,733,587       5,733,587  
(Loss)/earnings per shares - basic   $ (0.00 )     0.11     $ (0.06 )     0.12  
(Loss)/earnings per shares - diluted   $ (0.00 )     0.11     $ (0.06 )     0.12  

 

For the three and nine-month periods ended September 30, 2019, options to purchase 540,000 ordinary shares, were anti-dilutive due to net loss during the periods presented. For the three and nine-month periods ended September 30, 2018, options to purchase 250,000 ordinary shares were anti-dilutive due to the sum of the proceeds, including unrecognized compensation expense, exceeded the average market price of the Company’s ordinary share during the periods presented.

 

For the three and nine-month periods ended September 30, 2019, 8,230,700 warrants to purchase an aggregate of 8,230,700 ordinary shares were anti-dilutive due to net loss during the periods presented. For the three and nine-month periods ended September 30, 2018, 8,230,700 warrants to purchase an aggregate of 8,230,700 ordinary shares were anti-dilutive because the exercise price of $7.50 exceeded the average market price of the Company’s ordinary share during the periods presented.

 

GAAP requires the Company to use the two-class method in computing basic (loss) earnings per share since holders of the Company’s restricted stock have the right to share in dividends, if declared, equally with common stockholders. These participating securities effect the computation of both basic and diluted (loss) earnings per share during periods of net (loss) earnings.

 

v3.19.3
Derivative Instruments
9 Months Ended
Sep. 30, 2019
Derivative Instrument Detail [Abstract]  
Derivative Instruments

Inward Industry Loss Warranty ("ILW") Swap

 

In January 2018, the Company entered into an inward ILW swap (the "2018 Inward ILW Swap") with a third-party under which qualifying loss payments are triggered by reference to the level of losses incurred by the insurance industry as a whole, rather than by losses incurred by the insured. In return for a fixed payment received of $1 million, the Company was required to make a floating payment in the event of certain losses incurred from specified natural catastrophes in North America, Caribbean, Europe, Japan, Australia, New Zealand and Latin America from January 2018 to December 2018. The Company’s maximum payment obligation under the 2018 Inward ILW Swap was $4 million. The ILW Swap expired on December 31, 2018 and the Company did not renew the ILW Swap during the nine-month period ending September 30, 2019.

 

During the nine months ending September 30, 2019, the Company settled its payment obligation of $4 million under the 2018 Inward ILW Swap.

 

v3.19.3
(Loss) Earnings Per Share (Details Narrative) - shares
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Employee Stock Option        
Antidilutive securities excluded from computation of earnings per share 540,000 250,000 540,000 250,000
Warrants        
Antidilutive securities excluded from computation of earnings per share 8,230,700 8,230,700 8,230,700 8,230,700
v3.19.3
Net Worth for Regulatory Purposes (Details Narrative)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
USD ($)
Sep. 30, 2019
USD ($)
Minimum prescribed capital requirement $ 500 $ 500
Oxbridge Reinsurance Limited    
Subsidiary net worth 1,500 1,500
Subsidiary's net income (loss) (159) (754)
Oxbridge Re NS    
Subsidiary net worth 79 79
Subsidiary's net income (loss) $ 30 $ 61
v3.19.3
Organization and Basis of Presentation
9 Months Ended
Sep. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization and Basis of Presentation
(a) Organization

 

Oxbridge Re Holdings Limited (the “Company”) was incorporated as an exempted company on April 4, 2013 under the laws of the Cayman Islands. Oxbridge Re Holdings Limited owns 100% of the equity interest in Oxbridge Reinsurance Limited, an exempted entity incorporated on April 23, 2013 under the laws of the Cayman Islands and for which a Class “C” Insurer’s license was granted on April 29, 2013 under the provisions of the Cayman Islands Insurance Law. Oxbridge Re Holdings Limited also owns 100% of the equity interest in Oxbridge Re NS, an entity incorporated as an exempted company on December 22, 2017 under the laws of the Cayman Islands to function as a reinsurance sidecar facility and to increase the underwriting capacity of Oxbridge Reinsurance Limited. The Company, through its subsidiaries (collectively “Oxbridge Re”) provides collateralized reinsurance in the property catastrophe market and invests in various insurance-linked securities. The Company operates as a single business segment through its wholly-owned subsidiaries. The Company’s headquarters and principal executive offices are located at Suite 201, 42 Edward Street, Georgetown, Grand Cayman, Cayman Islands, and have their registered offices at P.O. Box 309, Ugland House, Grand Cayman, Cayman Islands.

 

The Company’s ordinary shares and warrants are listed on The NASDAQ Capital Market under the symbols “OXBR” and “OXBRW,” respectively.

 

(b) Basis of Presentation and Consolidation

 

The accompanying unaudited, consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information, and the Securities and Exchange Commission (“SEC”) rules for interim financial reporting. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with GAAP have been omitted pursuant to such rules and regulations. However, in the opinion of management, the accompanying interim consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the Company’s consolidated financial position as of September 30, 2019 and the consolidated results of operations and cash flows for the periods presented. The consolidated results of operations for interim periods are not necessarily indicative of the results of operations to be expected for any subsequent interim period or for the fiscal year ended December 31, 2019. The accompanying unaudited consolidated financial statements and notes thereto should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2018 included in the Company’s Form 10-K, which was filed with the SEC on March 19, 2019.

 

In preparing the interim unaudited consolidated financial statements, management was required to make certain estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and related disclosures at the financial reporting date and throughout the periods being reported upon. Certain of the estimates result from judgments that can be subjective and complex and consequently actual results may differ from these estimates, which would be reflected in future periods.

 

Material estimates that are particularly susceptible to significant change in the near-term relate to the determination of the reserve for losses and loss adjustment expenses, which include amounts estimated for claims incurred but not yet reported. The Company uses various assumptions and actuarial data it believes to be reasonable under the circumstances to make these estimates. In addition, accounting policies specific to valuation of investments and assessment of other-than-temporary impairment (“OTTI”) may involve significant judgments and estimates material to the Company’s consolidated financial statements. Although considerable variability is likely to be inherent in these estimates, management believes that any amounts provided are reasonable. These estimates are continually reviewed and adjusted if necessary. Such adjustments are reflected in current operations.

 

The Company consolidates in these consolidated financial statements the results of operations and financial position of all voting interest entities (“VOE”) in which the Company has a controlling financial interest and all variable interest entities (“VIE”) in which the Company is considered to be the primary beneficiary. The consolidation assessment, including the determination as to whether an entity qualifies as a VIE or VOE, depends on the facts and circumstances surrounding each entity.

 

All significant intercompany balances and transactions have been eliminated.

 

v3.19.3
(Loss) Earnings Per Share (Tables)
9 Months Ended
Sep. 30, 2019
Earnings Per Share [Abstract]  
Computation of basic and diluted (loss) earnings per share
    Three Months Ended     Nine Months Ended  
     September 30,      September 30,  
    2019     2018     2019     2018  
                         
Numerator:                        
     Net (loss) earnings   $ (15 )     652     $ (366 )     706  
                                 
Denominator:                                
    Weighted average shares - basic     5,733,587       5,733,587       5,733,587       5,733,587  
    Effect of dilutive securities - Stock options     -       -       -       -  
    Shares issuable upon conversion of warrants     -       -       -       -  
    Weighted average shares - diluted     5,733,587       5,733,587       5,733,587       5,733,587  
(Loss)/earnings per shares - basic   $ (0.00 )     0.11     $ (0.06 )     0.12  
(Loss)/earnings per shares - diluted   $ (0.00 )     0.11     $ (0.06 )     0.12  
v3.19.3
Significant Accounting Policies (Policies)
9 Months Ended
Sep. 30, 2019
Accounting Policies [Abstract]  
Cash and cash equivalents

Cash and cash equivalents: Cash and cash equivalents are comprised of cash and short- term investments with original maturities of three months or less.

 

Restricted cash and cash equivalents

Restricted cash and cash equivalents: Restricted cash and cash equivalents represent funds held in accordance with the Company’s trust agreements with ceding insurers and trustees, which requires the Company to maintain collateral with a market value greater than or equal to the limit of liability, less unpaid premium.

 

Investments

Investments: The Company’s investments consist of fixed-maturity securities and equity securities, and for which its fixed-maturity securities are classified as available-for-sale. The Company’s available for sale investments are carried at fair value with changes in fair value included as a separate component of accumulated other comprehensive income in shareholders’ equity. For the Company’s investment in equity securities, the changes in fair value are recorded within the consolidated statements of operations.

 

Unrealized gains or losses are determined by comparing the fair market value of the securities with their cost or amortized cost. Realized gains and losses on investments are recorded on the trade date and are included in the consolidated statements of operations. The cost of securities sold is based on the specified identification method. Investment income is recognized as earned and discounts or premiums arising from the purchase of debt securities are recognized in investment income using the interest method over the remaining term of the security.

 

The Company reviews all fixed-maturity securities for other-than-temporary impairment on a quarterly basis and more frequently when economic or market conditions warrant such review. When the fair value of any investment is lower than its cost, an assessment is made to see whether the decline is temporary or other-than-temporary. If the decline is determined to be other-than-temporary the investment is written down to fair value and an impairment charge is recognized in operations in the period in which the Company makes such determination. For a fixed-maturity security that the Company does not intend to sell nor is it more likely than not that the Company will be required to sell before recovery of its amortized cost, only the credit loss component is recognized in operations, while impairment related to all other factors is recognized in other comprehensive income. The Company considers various factors in determining whether an individual security is other-than-temporarily impaired.

 

Fair value measurement

Fair value measurement: GAAP establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under GAAP are as follows:

 

Level 1 Inputs that reflect unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date;
   
Level 2 Inputs other than quoted prices that are observable for the asset or liability either directly or indirectly, including inputs in markets that are not considered to be active; and
   
Level 3 Inputs that are unobservable.

 

Inputs are used in applying the various valuation techniques and broadly refer to the assumptions that market participants use to make valuation decisions, including assumptions about risk. For fixed maturity securities, inputs may include price information, volatility statistics, specific and broad credit data, liquidity statistics, broker quotes for similar securities and other factors. The fair value of investments in stocks and exchange-traded funds is based on the last traded price. A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. However, the determination of what constitutes “observable” requires significant judgment by the Company’s investment custodians. The investment custodians consider observable data to be market data which is readily available, regularly distributed or updated, reliable and verifiable, not proprietary, and provided by independent sources that are actively involved in the relevant markets. The categorization of a financial instrument within the hierarchy is based upon the pricing transparency of the instrument.

 

Derivative financial instruments

Derivative Financial Instruments: The Company may from time to time enter into underwriting contracts such as industry loss warranty contracts (“ILW”) that are treated as derivatives for GAAP purposes. GAAP requires that an entity recognize all derivatives in the consolidated balance sheet at fair value. It also requires that unrealized gains and losses resulting from changes in fair value be included in operations or comprehensive (loss) income. The Company did not have any derivative financial assets at September 30, 2019 or December 31, 2018. There were no derivative financial liabilities at September 30, 2019, and all derivative financial liabilities at December 31, 2018 have been included within reserve for losses and loss adjustment expenses.

 

Deferred policy acquisition costs ("DAC")

Deferred policy acquisition costs (“DAC”): Policy acquisition costs consist of brokerage fees, federal excise taxes and other costs related directly to the successful acquisition of new or renewal insurance contracts and are deferred and amortized over the terms of the reinsurance agreements to which they relate. The Company evaluates the recoverability of DAC by determining if the sum of future earned premiums and anticipated investment income is greater than the expected future claims and expenses. If a loss is probable on the unexpired portion of policies in force, a premium deficiency loss is recognized. At September 30, 2019, the DAC was considered fully recoverable and no premium deficiency loss was recorded.

Property and equipment

Property and equipment:  Property and equipment are recorded at cost when acquired. Property and equipment are comprised of motor vehicles, furniture and fixtures, computer equipment and leasehold improvements and are depreciated, using the straight-line method, over their estimated useful lives, which are five years for furniture and fixtures and computer equipment and four years for motor vehicles. Leasehold improvements are amortized over the lesser of the estimated useful lives of the assets or remaining lease term. The Company periodically reviews property and equipment that have finite lives, and that are not held for sale, for impairment by comparing the carrying value of the assets to their estimated future undiscounted cash flows. For the three-month and nine-month periods ended September 30, 2019 and 2018, there were no impairments in property and equipment.

 

Allowance for uncollectible receivables

Allowance for uncollectible receivables: Management evaluates credit quality by evaluating the exposure to individual counterparties; where warranted management also considers the credit rating or financial position, operating results and/or payment history of the counterparty. Management establishes an allowance for amounts for which collection is considered doubtful. Adjustments to previous assessments are recognized as income in the year in which they are determined. At September 30, 2019, no receivables were determined to be overdue or impaired and, accordingly, no allowance for uncollectible receivables has been established.

 

Reserves for losses and loss adjustment expenses

Reserves for losses and loss adjustment expenses: The Company determines its reserves for losses and loss adjustment expenses on the basis of the claims reported by the Company’s ceding insurers and for losses incurred but not reported (“IBNR”), management uses the assistance of an independent actuary. The reserves for losses and loss adjustment expenses represent management’s best estimate of the ultimate settlement costs of all losses and loss adjustment expenses. Management believes that the amounts are adequate; however, the inherent impossibility of predicting future events with precision, results in uncertainty as to the amount which will ultimately be required for the settlement of losses and loss expenses, and the differences could be material. Adjustments are reflected in the consolidated statements of operations in the period in which they are determined.

 

Loss experience refund payable

Loss experience refund payable: Certain contracts may include retrospective provisions that adjust premiums or result in profit commissions in the event losses are minimal or zero. In accordance with GAAP, the Company will recognize a liability in the period in which the absence of loss experience obligates the Company to pay cash or other consideration under the contracts. On the contrary, the Company will derecognize such liability in the period in which a loss experience arises. Such adjustments to the liability, which accrue throughout the contract terms, will reduce the liability should a catastrophic loss event covered by the Company occur.

 

Premiums assumed

Premiums assumed: The Company records premiums assumed, net of loss experience refunds, as earned pro-rata over the terms of the reinsurance agreements, or period of risk, where applicable, and the unearned portion at the consolidated balance sheet date is recorded as unearned premiums reserve. A reserve is made for estimated premium deficiencies to the extent that estimated losses and loss adjustment expenses exceed related unearned premiums. Investment income is not considered in determining whether or not a deficiency exists.

 

Subsequent adjustments of premiums assumed, based on reports of actual premium by the ceding companies, or revisions in estimates of ultimate premium, are recorded in the period in which they are determined. Such adjustments are generally determined after the associated risk periods have expired, in which case the premium adjustments are fully earned when assumed.

 

Certain contracts may allow for reinstatement premiums in the event of a full limit loss prior to the expiration of the contract. A reinstatement premium is not due until there is a full limit loss event and therefore, in accordance with GAAP, the Company records a reinstatement premium as written only in the event that the reinsured incurs a full limit loss on the contract and the contract allows for a reinstatement of coverage upon payment of an additional premium. For catastrophe contracts which contractually require the payment of a reinstatement premium equal to or greater than the original premium upon the occurrence of a full limit loss, the reinstatement premiums are earned over the original contract period. Reinstatement premiums that are contractually calculated on a pro-rata basis of the original premiums are earned over the remaining coverage period.

Unearned premiums ceded

Unearned Premiums Ceded: The Company reduces the risk of future losses on business assumed by reinsuring certain risks and exposures with other reinsurers (retrocessionaires). The Company remains liable to the extent that any retrocessionaire fails to meet its obligations and to the extent that the Company does not hold sufficient security for their unpaid obligations.

 

Ceded premiums are written during the period in which the risk incept and are expensed over the contract period in proportion to the period of protection. Unearned premiums ceded consist of the unexpired portion of the reinsurance obtained.

 

Uncertain income tax positions

Uncertain income tax positions: The authoritative GAAP guidance on accounting for, and disclosure of, uncertainty in income tax positions requires the Company to determine whether an income tax position of the Company is more likely than not to be sustained upon examination by the relevant tax authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position.

 

For income tax positions meeting the more likely than not threshold, the tax amount recognized in the consolidated financial statements, if any, is reduced by the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement with the relevant taxing authority. The application of this authoritative guidance has had no effect on the Company’s consolidated financial statements because the Company had no uncertain tax positions at September 30, 2019.

 

(Loss) earnings per share

(Loss) Earnings Per Share: Basic (loss) earnings per share has been computed on the basis of the weighted-average number of ordinary shares outstanding during the periods presented. Diluted (loss) earnings per share is computed based on the weighted-average number of ordinary shares outstanding and reflects the assumed exercise or conversion of diluted securities, such as stock options and warrants, computed using the treasury stock method.

Stock-based compensation

Stock-Based Compensation: The Company accounts for stock-based compensation under the fair value recognition provisions of GAAP which requires the measurement and recognition of compensation for all stock-based awards made to employees and directors, including stock options and restricted stock issuances based on estimated fair values. The Company measures compensation for restricted stock based on the price of the Company’s ordinary shares at the grant date. Determining the fair value of stock options at the grant date requires significant estimation and judgment. The Company uses an option-pricing model (Black-Scholes option pricing model) to assist in the calculation of fair value for stock options. The Company's shares have not been publicly traded for a sufficient length of time to solely use the Company's performance to reasonably estimate the expected volatility. Therefore, when estimating the expected volatility, the Company takes into consideration the historical volatility of similar entities. The Company considers factors such as an entity's industry, stage of life cycle, size and financial leverage when selecting similar entities. The Company may use a sample peer group of companies in the reinsurance industry and/or the Company’s own historical volatility in determining the expected volatility. Additionally, the Company uses the full life of the options, ten years, as the estimated term of the options, and has assumed no forfeitures during the life of the options.

 

The Company uses the straight-line attribution method for all grants that include only a service condition. Compensation expense related to all awards is included in general and administrative expenses. 

 

Recent accounting pronouncements

Recent Adopted Accounting Pronouncements:

 

Accounting Standards Update No. 2016-02. In February 2016, the FASB issued ASU 2016-02, "Leases (Topic 842)," which supersedes Topic 840 and creates the new lease accounting standards for lessees and lessors, primarily related to the recognition of lease assets and liabilities by lessees for leases classified as operating leases. Under previous guidance for lessees, leases were only included on the balance sheet if certain criteria, classifying the agreement as a capital lease, were met. This update requires the recognition of a right-of-use asset and a corresponding lease liability, discounted to the present value, for all leases that extend beyond 12 months.

 

For operating leases, the asset and liability are expensed over the lease term on a straight-line basis, with all cash flows included in the operating section of the statement of cash flows. For finance leases, interest on the lease liability is recognized separately from the amortization of the right-of-use asset in the consolidated statement of comprehensive operations and the repayment of the principal portion of the lease liability is classified as a financing activity while the interest component is included in the operating section of the consolidated statement of cash flows.

 

We adopted ASU 2016-02, ASU 2018-10 Codification Improvements to Topic 842: Leases and ASU 2018-11 Leases (Topic 842): Targeted Improvements on January 1, 2019.  We applied the standards using the alternative transition method provided by ASU 2018-11 under which leases were recognized at the date of adoption and a cumulative-effective adjustment to the opening balance of retained earnings would have been recognized in the period of adoption. As the standard did not have an impact on our net (loss) earnings, no adjustment to the opening balance of retained earnings was required. As of September 30, 2019, $140 thousand of right-of-use assets and $140 thousand of lease liabilities for operating leases were added as operating lease right-of-use assets and operating lease liabilities line items, respectively, on the consolidated balance sheet as a result of the adoption of this update. We implemented controls for the adoption of the standard and the ongoing monitoring of the right-of-use asset and lease liability, but they did not materially affect our internal control over financial reporting.

 

Pending Accounting Updates:

 

 Accounting Standards Update No. 2016-13. In June 2016, the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurements of Credit Losses on Financial Instruments” (“ASU 2016-13”). ASU 2016-13 amends the guidance on reporting credits losses and affects loans, debt securities, trade receivables, reinsurance recoverable and other financial assets that have the contractual right to receive cash. The amendments are effective for annual periods beginning after December 15, 2019, and interim periods within those annual periods. The Company is in the process of evaluating the impact of the requirements of ASU 2016-13 on the Company’s consolidated financial statements and anticipates implementing ASU 2016-13 during the first quarter of fiscal year 2020. In July 2019, the FASB board voted to ask its staff to prepare an exposure draft proposing the new effective dates for ASU No. 2016-13. If approved, the new effective date for the Company would be January 1, 2023.

 

Accounting Standards Update No. 2018-13. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820) - Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement (“ASU 2018-13”).  ASU 2018-13 removes, modifies and adds certain disclosure requirements associated with fair value measurements. ASU 2018-13 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019.  The removed and modified disclosures will be adopted on a retrospective basis and the new disclosures will be adopted on a prospective basis. We are currently evaluating our timeline for the adoption of this ASU, which only affects the presentation of certain disclosures and is not expected to impact our results of operations, financial position or liquidity.

Segment information

Segment Information: Under GAAP, operating segments are based on the internal information that management uses for allocating resources and assessing performance as the source of the Company’s reportable segments. The Company manages its business on the basis of one operating segment, Property and Casualty Reinsurance, in accordance with the qualitative and quantitative criteria established under GAAP.

 

Reclassifications

Reclassifications: Any reclassifications of prior period amounts have been made to conform to the current period presentation.

 

v3.19.3
Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Revenue        
Assumed premiums $ 0 $ 47 $ 1,116 $ 2,627
Change in loss experience refund payable 0 0 0 (225)
Change in unearned premiums reserve 279 653 (744) (1,148)
Net premiums earned 279 700 372 1,254
Net income from derivative instruments 0 397 0 773
Net investment and other income 54 100 182 280
Net realized investment losses 0 (61) 3 (237)
Change in fair value of equity securities 17 118 20 22
Total revenue 350 1,254 577 2,092
Expenses        
Net loss on commutation 0 0 0 8
Policy acquisition costs and underwriting expenses 31 63 41 101
General and administrative expenses 264 305 808 981
Total expenses 295 368 849 1,090
Income (loss) before (income) attributable to Series 2019-1 noteholders 55 886 (272) 1,002
(Income) attributable to Series 2019-1 noteholders (70) (234) (94) (296)
Net (loss) income $ (15) $ 652 $ (366) $ 706
(Loss) earnings per share: basic and diluted $ (0.00) $ 0.11 $ (0.06) $ 0.12
Dividends paid per share $ .00 $ .00 $ .00 $ .00
v3.19.3
Fair Value and Certain Risks and Uncertainties
9 Months Ended
Sep. 30, 2019
Fair Value Disclosures [Abstract]  
Fair Value and Certain Risks and Uncertainties

Fair values

 

With the exception of balances in respect of insurance contracts (which are specifically excluded from fair value disclosures under GAAP) and investment securities and derivative instruments as disclosed in Note 4 and 5 of these consolidated financial statements, the carrying amounts of all other financial instruments, which consist of cash and cash equivalents, restricted cash and cash equivalents, accrued interest and dividends receivable, premiums receivable and other assets and accounts payable and other liabilities, approximate their fair values due to their short-term nature.

 

Concentration of underwriting risk

 

As the Company’s current reinsurance business ultimately relates to the risks of a limited number of entities, the Company’s underwriting risks are not significantly diversified.

 

Concentrations of Credit and Counterparty Risk

 

The Company’s derivative instruments are subject to counterparty risk. The Company routinely monitor this risk.

 

The Company may market retrocessional and reinsurance policies worldwide through its brokers.  Credit risk exists to the extent that any of these brokers may be unable to fulfill their contractual obligations to the Company.  For example, the Company is required to pay amounts owed on claims under policies to brokers, and these brokers, in the Company. In some jurisdictions, if a broker fails to make such a payment, the Company might remain liable to the ceding company for the deficiency. In addition, in certain jurisdictions, when the ceding company pays premiums for these policies to brokers, these premiums are considered to have been paid and the ceding insurer is no longer liable to the Company for those amounts, whether or not the premiums have actually been received.

 

The Company remains liable for losses it incurs to the extent that any third-party reinsurer is unable or unwilling to make timely payments under reinsurance agreements.  The Company would also be liable in the event that its ceding companies were unable to collect amounts due from underlying third-party reinsurers.

 

The Company mitigates its concentrations of credit and counterparty risk by using reputable and several counterparties which decreases the likelihood of any significant concentration of credit risk with any one counterparty. Additionally, the Company invests in fixed maturity securities that are investment grade or higher.

 

Market risk

 

Market risk exists to the extent that the values of the Company’s monetary assets fluctuate as a result of changes in market prices. Changes in market prices can arise from factors specific to individual securities or their respective issuers, or factors affecting all securities traded in a particular market. Relevant factors for the Company are both volatility and liquidity of specific securities and markets in which the Company holds investments. The Company has established investment guidelines that seek to mitigate significant exposure to market risk.

 

v3.19.3
Related Party Transactions (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Revenue        
Assumed premiums $ 0 $ 47 $ 1,116 $ 2,627
Change in loss experience refund payable 0 0 0 (225)
Change in unearned premiums reserve 279 653 (744) (1,148)
Claddaugh And Hcpci        
Revenue        
Assumed premiums 0 0 0 0
Change in loss experience refund payable 0 0 0 (225)
Change in unearned premiums reserve $ 0 $ 0 $ 0 $ 592
v3.19.3
(Loss) Earnings Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Sep. 30, 2019
Sep. 30, 2018
Numerator:                
Net (loss) earnings $ (15) $ (205) $ (146) $ 652 $ 265 $ (211) $ (366) $ 706
Denominator:                
Weighted average shares - basic 5,733,587     5,733,587     5,733,587 5,733,587
Effect of dilutive securities - stock options 0     0     0 0
Shares issuable upon conversion of warrants 0     0     0 0
Weighted average shares - diluted 5,733,587     5,733,587     5,733,587 5,733,587
(Loss)/earnings per shares - basic $ (.00)     $ .11     $ (.06) $ .12
(Loss)/earnings per shares - diluted $ (.00)     $ .11     $ (.06) $ .12
v3.19.3
Share-Based Compensation (Details Narrative) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
General and Administrative Expense        
Stock compensation expense recognized $ 9 $ 9 $ 27 $ 29
General and Administrative Expense | Restricted Stock        
Stock compensation expense recognized $ 0 22 $ 0 65
Incentive Stock Option Plan        
Shares available for grant 400,000   400,000  
Share based compensation arrangement, vesting period     4 years  
Unrecognized compensation expense, non-vested stock options $ 95 25 $ 95 25
Unrecognized compensation cost, weighted average recognition period     33 months  
Unrecognized compensation expense, non-vested restricted stock $ 0 $ 22 $ 0 $ 22
v3.19.3
Cash and Cash Equivalents and Restricted Cash and Cash Equivalents (Tables)
9 Months Ended
Sep. 30, 2019
Cash and Cash Equivalents [Abstract]  
Summary of cash and cash equivalents and restricted cash and cash equivalents
    At September 30,     At December 31,  
    2019     2018  
    (in thousands)  
             
Cash on deposit   $ 3,468     $ 3,965  
Cash held with custodians     2,669       4,109  
Restricted cash held in trust     1,915       3,225  
                 
Total   8,052     $  11,299  
v3.19.3
Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Statement of Comprehensive Income [Abstract]        
Net (loss) income $ (15) $ 652 $ (366) $ 706
Change in unrealized loss on investments:        
Unrealized (loss) gain arising during the period 0 1 1 (3)
Reclassification adjustment for net realized losses (gains) included in net (loss) income 0 0 (3) 0
Net change in unrealized loss 0 1 (2) (3)
Total other comprehensive income (loss) 0 1 (2) (3)
Comprehensive (loss) income $ (15) $ 653 $ (368) $ 703
v3.19.3
Leases
9 Months Ended
Sep. 30, 2019
Leases [Abstract]  
Leases

We adopted ASU 2016-02, Leases on January 1, 2019, which resulted in the recognition of operating leases on the consolidated balance sheet in 2019 and forward. See Note 2 – Significant Accounting Policies for more information on the adoption of the ASU. Right-of-use assets and lease liabilities are disclosed as line in the consolidated balance sheet. We determine if a contract contains a lease at inception and recognize operating lease right-of-use assets and operating lease liabilities based on the present value of the future minimum lease payments at the commencement date. As our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments. Lease agreements that have lease and non-lease components, are accounted for as a single lease component. Lease expense is recognized on a straight-line basis over the lease term.

 

The Company’s operating lease obligations are for the Company’s office facilities. Our lease have remaining lease terms of approximately 53 months, and include an option to extend the lease. Under the terms of the lease, the Company also has the right to terminate the lease after thirty-six (36) months upon giving appropriate notice in writing to the Lessor. The components of lease expense and other lease information as of and during the three and nine-month period ended September 30, 2019 are as follows:

 

   

For the
Three-Month Period

   

For the
Nine-Month Period

 
(in thousands)  

Ended 
September 30,
2019

   

Ended
September 30,
2019

 
Operating Lease Cost (1)   $ 22     $ 63  
                 
Cash paid for amounts included in the measurement of lease liabilities                
Operating cash flows from operating leases   $ 22     $ 71  
                 
(1) Includes short-term leases                

 

(in thousands)  

At
September 30,
2019

 
Operating lease right-of-use assets   $ 140  
         
Operating lease liabilities   $ 140  
         
Weighted-average remaining lease term - operating leases   4.42 years  
         
Weighted-average discount rate - operating leases     6.5 %

 

Future minimum lease payments under non-cancellable leases as of September 30, 2019, reconciled to our discounted operating lease liability presented on the consolidated balance sheet are as follows:

 

(in thousands)  

At
September 30,
2019

   

At
December 31,
2018

 
Remainder of 2019   $ 9     $ -  
2020     36       -  
2021     36       -  
2022     37       -  
2023     37       -  
Thereafter     6       -  
Total future minimum lease payments   $ 161     $ -  
                 
Less imputed interest     (21 )     N/A  
Total operating lease liability   $ 140       N/A  

 

v3.19.3
Document and Entity Information - shares
9 Months Ended
Sep. 30, 2019
Nov. 04, 2019
Document And Entity Information [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Sep. 30, 2019  
Document Fiscal Year Focus 2019  
Document Fiscal Period Focus Q3  
Entity Registrant Name OXBRIDGE RE HOLDINGS Ltd  
Entity Central Index Key 0001584831  
Current Fiscal Year End Date --12-31  
Entity Filer Category Non-accelerated Filer  
Entity Emerging Growth Company true  
Entity Ex-Transition Period false  
Entity Small Business true  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   5,733,587
v3.19.3
Significant Accounting Policies
9 Months Ended
Sep. 30, 2019
Accounting Policies [Abstract]  
Significant Accounting Policies

Cash and cash equivalents: Cash and cash equivalents are comprised of cash and short- term investments with original maturities of three months or less.

 

Restricted cash and cash equivalents: Restricted cash and cash equivalents represent funds held in accordance with the Company’s trust agreements with ceding insurers and trustees, which requires the Company to maintain collateral with a market value greater than or equal to the limit of liability, less unpaid premium.

 

Investments: The Company’s investments consist of fixed-maturity securities and equity securities, and for which its fixed-maturity securities are classified as available-for-sale. The Company’s available for sale investments are carried at fair value with changes in fair value included as a separate component of accumulated other comprehensive income in shareholders’ equity. For the Company’s investment in equity securities, the changes in fair value are recorded within the consolidated statements of operations.

 

Unrealized gains or losses are determined by comparing the fair market value of the securities with their cost or amortized cost. Realized gains and losses on investments are recorded on the trade date and are included in the consolidated statements of operations. The cost of securities sold is based on the specified identification method. Investment income is recognized as earned and discounts or premiums arising from the purchase of debt securities are recognized in investment income using the interest method over the remaining term of the security.

 

The Company reviews all fixed-maturity securities for other-than-temporary impairment on a quarterly basis and more frequently when economic or market conditions warrant such review. When the fair value of any investment is lower than its cost, an assessment is made to see whether the decline is temporary or other-than-temporary. If the decline is determined to be other-than-temporary the investment is written down to fair value and an impairment charge is recognized in operations in the period in which the Company makes such determination. For a fixed-maturity security that the Company does not intend to sell nor is it more likely than not that the Company will be required to sell before recovery of its amortized cost, only the credit loss component is recognized in operations, while impairment related to all other factors is recognized in other comprehensive income. The Company considers various factors in determining whether an individual security is other-than-temporarily impaired.

 

Fair value measurement: GAAP establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under GAAP are as follows:

 

Level 1 Inputs that reflect unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date;
   
Level 2 Inputs other than quoted prices that are observable for the asset or liability either directly or indirectly, including inputs in markets that are not considered to be active; and
   
Level 3 Inputs that are unobservable.

 

Inputs are used in applying the various valuation techniques and broadly refer to the assumptions that market participants use to make valuation decisions, including assumptions about risk. For fixed maturity securities, inputs may include price information, volatility statistics, specific and broad credit data, liquidity statistics, broker quotes for similar securities and other factors. The fair value of investments in stocks and exchange-traded funds is based on the last traded price. A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. However, the determination of what constitutes “observable” requires significant judgment by the Company’s investment custodians. The investment custodians consider observable data to be market data which is readily available, regularly distributed or updated, reliable and verifiable, not proprietary, and provided by independent sources that are actively involved in the relevant markets. The categorization of a financial instrument within the hierarchy is based upon the pricing transparency of the instrument.

 

Derivative Financial Instruments: The Company may from time to time enter into underwriting contracts such as industry loss warranty contracts (“ILW”) that are treated as derivatives for GAAP purposes. GAAP requires that an entity recognize all derivatives in the consolidated balance sheet at fair value. It also requires that unrealized gains and losses resulting from changes in fair value be included in operations or comprehensive (loss) income. The Company did not have any derivative financial assets at September 30, 2019 or December 31, 2018. There were no derivative financial liabilities at September 30, 2019, and all derivative financial liabilities at December 31, 2018 have been included within reserve for losses and loss adjustment expenses.

 

Deferred policy acquisition costs (“DAC”): Policy acquisition costs consist of brokerage fees, federal excise taxes and other costs related directly to the successful acquisition of new or renewal insurance contracts and are deferred and amortized over the terms of the reinsurance agreements to which they relate. The Company evaluates the recoverability of DAC by determining if the sum of future earned premiums and anticipated investment income is greater than the expected future claims and expenses. If a loss is probable on the unexpired portion of policies in force, a premium deficiency loss is recognized. At September 30, 2019, the DAC was considered fully recoverable and no premium deficiency loss was recorded.

 

Property and equipment:  Property and equipment are recorded at cost when acquired. Property and equipment are comprised of motor vehicles, furniture and fixtures, computer equipment and leasehold improvements and are depreciated, using the straight-line method, over their estimated useful lives, which are five years for furniture and fixtures and computer equipment and four years for motor vehicles. Leasehold improvements are amortized over the lesser of the estimated useful lives of the assets or remaining lease term. The Company periodically reviews property and equipment that have finite lives, and that are not held for sale, for impairment by comparing the carrying value of the assets to their estimated future undiscounted cash flows. For the three-month and nine-month periods ended September 30, 2019 and 2018, there were no impairments in property and equipment.

 

Allowance for uncollectible receivables: Management evaluates credit quality by evaluating the exposure to individual counterparties; where warranted management also considers the credit rating or financial position, operating results and/or payment history of the counterparty. Management establishes an allowance for amounts for which collection is considered doubtful. Adjustments to previous assessments are recognized as income in the year in which they are determined. At September 30, 2019, no receivables were determined to be overdue or impaired and, accordingly, no allowance for uncollectible receivables has been established.

 

Reserves for losses and loss adjustment expenses: The Company determines its reserves for losses and loss adjustment expenses on the basis of the claims reported by the Company’s ceding insurers and for losses incurred but not reported (“IBNR”), management uses the assistance of an independent actuary. The reserves for losses and loss adjustment expenses represent management’s best estimate of the ultimate settlement costs of all losses and loss adjustment expenses. Management believes that the amounts are adequate; however, the inherent impossibility of predicting future events with precision, results in uncertainty as to the amount which will ultimately be required for the settlement of losses and loss expenses, and the differences could be material. Adjustments are reflected in the consolidated statements of operations in the period in which they are determined.

 

Loss experience refund payable: Certain contracts may include retrospective provisions that adjust premiums or result in profit commissions in the event losses are minimal or zero. In accordance with GAAP, the Company will recognize a liability in the period in which the absence of loss experience obligates the Company to pay cash or other consideration under the contracts. On the contrary, the Company will derecognize such liability in the period in which a loss experience arises. Such adjustments to the liability, which accrue throughout the contract terms, will reduce the liability should a catastrophic loss event covered by the Company occur.

 

Premiums assumed: The Company records premiums assumed, net of loss experience refunds, as earned pro-rata over the terms of the reinsurance agreements, or period of risk, where applicable, and the unearned portion at the consolidated balance sheet date is recorded as unearned premiums reserve. A reserve is made for estimated premium deficiencies to the extent that estimated losses and loss adjustment expenses exceed related unearned premiums. Investment income is not considered in determining whether or not a deficiency exists.

 

Subsequent adjustments of premiums assumed, based on reports of actual premium by the ceding companies, or revisions in estimates of ultimate premium, are recorded in the period in which they are determined. Such adjustments are generally determined after the associated risk periods have expired, in which case the premium adjustments are fully earned when assumed.

 

Certain contracts may allow for reinstatement premiums in the event of a full limit loss prior to the expiration of the contract. A reinstatement premium is not due until there is a full limit loss event and therefore, in accordance with GAAP, the Company records a reinstatement premium as written only in the event that the reinsured incurs a full limit loss on the contract and the contract allows for a reinstatement of coverage upon payment of an additional premium. For catastrophe contracts which contractually require the payment of a reinstatement premium equal to or greater than the original premium upon the occurrence of a full limit loss, the reinstatement premiums are earned over the original contract period. Reinstatement premiums that are contractually calculated on a pro-rata basis of the original premiums are earned over the remaining coverage period.

 

Unearned Premiums Ceded: The Company reduces the risk of future losses on business assumed by reinsuring certain risks and exposures with other reinsurers (retrocessionaires). The Company remains liable to the extent that any retrocessionaire fails to meet its obligations and to the extent that the Company does not hold sufficient security for their unpaid obligations.

 

Ceded premiums are written during the period in which the risk incept and are expensed over the contract period in proportion to the period of protection. Unearned premiums ceded consist of the unexpired portion of the reinsurance obtained.

 

Uncertain income tax positions: The authoritative GAAP guidance on accounting for, and disclosure of, uncertainty in income tax positions requires the Company to determine whether an income tax position of the Company is more likely than not to be sustained upon examination by the relevant tax authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position.

 

For income tax positions meeting the more likely than not threshold, the tax amount recognized in the consolidated financial statements, if any, is reduced by the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement with the relevant taxing authority. The application of this authoritative guidance has had no effect on the Company’s consolidated financial statements because the Company had no uncertain tax positions at September 30, 2019.

 

(Loss) Earnings Per Share: Basic (loss) earnings per share has been computed on the basis of the weighted-average number of ordinary shares outstanding during the periods presented. Diluted (loss) earnings per share is computed based on the weighted-average number of ordinary shares outstanding and reflects the assumed exercise or conversion of diluted securities, such as stock options and warrants, computed using the treasury stock method.

 

Stock-Based Compensation: The Company accounts for stock-based compensation under the fair value recognition provisions of GAAP which requires the measurement and recognition of compensation for all stock-based awards made to employees and directors, including stock options and restricted stock issuances based on estimated fair values. The Company measures compensation for restricted stock based on the price of the Company’s ordinary shares at the grant date. Determining the fair value of stock options at the grant date requires significant estimation and judgment. The Company uses an option-pricing model (Black-Scholes option pricing model) to assist in the calculation of fair value for stock options. The Company's shares have not been publicly traded for a sufficient length of time to solely use the Company's performance to reasonably estimate the expected volatility. Therefore, when estimating the expected volatility, the Company takes into consideration the historical volatility of similar entities. The Company considers factors such as an entity's industry, stage of life cycle, size and financial leverage when selecting similar entities. The Company may use a sample peer group of companies in the reinsurance industry and/or the Company’s own historical volatility in determining the expected volatility. Additionally, the Company uses the full life of the options, ten years, as the estimated term of the options, and has assumed no forfeitures during the life of the options.

 

The Company uses the straight-line attribution method for all grants that include only a service condition. Compensation expense related to all awards is included in general and administrative expenses. 

 

Recent Adopted Accounting Pronouncements:

 

Accounting Standards Update No. 2016-02. In February 2016, the FASB issued ASU 2016-02, "Leases (Topic 842)," which supersedes Topic 840 and creates the new lease accounting standards for lessees and lessors, primarily related to the recognition of lease assets and liabilities by lessees for leases classified as operating leases. Under previous guidance for lessees, leases were only included on the balance sheet if certain criteria, classifying the agreement as a capital lease, were met. This update requires the recognition of a right-of-use asset and a corresponding lease liability, discounted to the present value, for all leases that extend beyond 12 months.

 

For operating leases, the asset and liability are expensed over the lease term on a straight-line basis, with all cash flows included in the operating section of the statement of cash flows. For finance leases, interest on the lease liability is recognized separately from the amortization of the right-of-use asset in the consolidated statement of comprehensive operations and the repayment of the principal portion of the lease liability is classified as a financing activity while the interest component is included in the operating section of the consolidated statement of cash flows.

 

We adopted ASU 2016-02, ASU 2018-10 Codification Improvements to Topic 842: Leases and ASU 2018-11 Leases (Topic 842): Targeted Improvements on January 1, 2019.  We applied the standards using the alternative transition method provided by ASU 2018-11 under which leases were recognized at the date of adoption and a cumulative-effective adjustment to the opening balance of retained earnings would have been recognized in the period of adoption. As the standard did not have an impact on our net (loss) earnings, no adjustment to the opening balance of retained earnings was required. As of September 30, 2019, $140 thousand of right-of-use assets and $140 thousand of lease liabilities for operating leases were added as operating lease right-of-use assets and operating lease liabilities line items, respectively, on the consolidated balance sheet as a result of the adoption of this update. We implemented controls for the adoption of the standard and the ongoing monitoring of the right-of-use asset and lease liability, but they did not materially affect our internal control over financial reporting.

 

Pending Accounting Updates:

 

 Accounting Standards Update No. 2016-13. In June 2016, the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurements of Credit Losses on Financial Instruments” (“ASU 2016-13”). ASU 2016-13 amends the guidance on reporting credits losses and affects loans, debt securities, trade receivables, reinsurance recoverable and other financial assets that have the contractual right to receive cash. The amendments are effective for annual periods beginning after December 15, 2019, and interim periods within those annual periods. The Company is in the process of evaluating the impact of the requirements of ASU 2016-13 on the Company’s consolidated financial statements and anticipates implementing ASU 2016-13 during the first quarter of fiscal year 2020. In July 2019, the FASB board voted to ask its staff to prepare an exposure draft proposing the new effective dates for ASU No. 2016-13. If approved, the new effective date for the Company would be January 1, 2023.

 

Accounting Standards Update No. 2018-13. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820) - Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement (“ASU 2018-13”).  ASU 2018-13 removes, modifies and adds certain disclosure requirements associated with fair value measurements. ASU 2018-13 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019.  The removed and modified disclosures will be adopted on a retrospective basis and the new disclosures will be adopted on a prospective basis. We are currently evaluating our timeline for the adoption of this ASU, which only affects the presentation of certain disclosures and is not expected to impact our results of operations, financial position or liquidity.

 

Segment Information: Under GAAP, operating segments are based on the internal information that management uses for allocating resources and assessing performance as the source of the Company’s reportable segments. The Company manages its business on the basis of one operating segment, Property and Casualty Reinsurance, in accordance with the qualitative and quantitative criteria established under GAAP.

 

Reclassifications: Any reclassifications of prior period amounts have been made to conform to the current period presentation.

 

v3.19.3
Share-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2019
Share-based Payment Arrangement [Abstract]  
Summary of stock option activity
   

Number

of

Options

   

Weighted-

Average

Exercise

Price

 

Weighted-

Average

Remaining

Contractual

Term

 

Aggregate

Intrinsic

Value

 
                     
Outstanding at January 1, 2019     250,000                
Granted     290,000     $ 2.00          
Outstanding at March 31, 2019     540,000     $ 3.86    8.1 years   $ -  
Outstanding at June 30, 2019     540,000     $ 3.86    7.9 years   $ -  
Outstanding at September 30, 2019     540,000     $ 3.86    7.6 years   $ -  
Exercisable at September 30, 2019     291,250     $ 5.26    6.3 years   $ -  
                           
                           
Outstanding at January 1, 2018     250,000     $ 6.01            
Outstanding at March 31, 2018     250,000     $ 6.01    7.2 years   $ -  
Outstanding at June 30, 2018     250,000     $ 6.01    6.9 years   $ -  
Outstanding at September 30, 2018     250,000     $ 6.01    6.7 years   $ -  
Exercisable at September 30, 2018     208,125     $ 6.01    6.7 years   $ -  
Estimated fair value of options granted using black-scholes option-pricing model with weighted-average assumptions
    2019  
       
Expected dividend yield     0 %
Expected volatility     31 %
Risk-free interest rate     3 %
Expected life (in years)     10  
Per share grant date fair value of options issued   $ 0.36  
v3.19.3
Investments (Details Narrative)
$ in Thousands
Dec. 31, 2018
USD ($)
Investments, Debt and Equity Securities [Abstract]  
Fair value of securities held in trust accounts $ 993
v3.19.3
Leases (Tables)
9 Months Ended
Sep. 30, 2019
Leases [Abstract]  
Operating lease obligations
    For the
Three-Month Period
    For the
Nine-Month Period
 
(in thousands)   Ended 
September 30,

2019
    Ended
September 30,

2019
 
Operating Lease Cost (1)   $ 22     $ 63  
                 
Cash paid for amounts included in the measurement of lease liabilities                
Operating cash flows from operating leases   $ 22     $ 71  
                 
(1) Includes short-term leases                

 

(in thousands)   At
September 30,

2019
 
Operating lease right-of-use assets   $ 140  
         
Operating lease liabilities   $ 140  
         
Weighted-average remaining lease term - operating leases   4.42 years  
         
Weighted-average discount rate - operating leases     6.5 %

 

Future minimum lease payments
(in thousands)  

At
September 30,
2019

   

At
December 31,
2018

 
Remainder of 2019   $ 9     $ -  
2020     36       -  
2021     36       -  
2022     37       -  
2023     37       -  
Thereafter     6       -  
Total future minimum lease payments   $ 161     $ -  
                 
Less imputed interest     (21 )     N/A  
Total operating lease liability   $ 140       N/A  
v3.19.3
Cash and Cash Equivalents and Restricted Cash and Cash Equivalents (Details) - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Cash and Cash Equivalents [Abstract]    
Cash on deposit $ 3,468 $ 3,965
Cash held with custodians 2,669 4,109
Restricted cash held in trust 1,915 3,225
Total $ 8,052 $ 11,299
v3.19.3
Shareholders' Equity
9 Months Ended
Sep. 30, 2019
Equity [Abstract]  
Shareholders' Equity

On February 28, 2014, the Company’s Registration Statement on Form S-1, as amended, relating to the initial public offering of the Company’s units was declared effective by the SEC. The Registration Statement covered the offer and sale by the Company of 4,884,650 units, each consisting of one ordinary share and one warrant (“Unit”), which were sold to the public on March 26, 2014 at a price of $6.00 per Unit. The ordinary shares and warrants comprising the Units began separate trading on May 9, 2014. The ordinary shares and warrants are traded on the Nasdaq Capital Market under the symbols “OXBR” and “OXBRW,” respectively. One warrant may be exercised to acquire one ordinary share at an exercise price equal to $7.50 per share on or before March 26, 2024, as amended. At any time after September 26, 2014 and before the expiration of the warrants, the Company at its option may cancel the warrants in whole or in part, provided that the closing price per ordinary share has exceeded $9.38 for at least ten trading days within any period of twenty consecutive trading days, including the last trading day of the period.

 

The initial public offering resulted in aggregate gross proceeds to the Company of approximately $29.3 million (of which approximately $5 million related to the fair value proceeds on the warrants issued) and net proceeds of approximately $26.9 million after deducting underwriting commissions and offering expenses.

 

There were 8,230,700 warrants outstanding at September 30, 2019 and 2018. No warrants were exercised during the three and nine-month periods ended September 30, 2019 and 2018.

 

As of September 30, 2019, none of the Company’s retained earnings were restricted from payment of dividends to the company’s shareholders. However, since most of the Company’s capital and retained earnings may be invested in its subsidiaries, a dividend from the subsidiaries would likely be required in order to fund a dividend to the Company’s shareholders and would require notification to the Cayman Islands Monetary Authority (“CIMA”).

 

Under Cayman Islands law, the use of additional paid-in capital is restricted, and the Company will not be allowed to pay dividends out of additional paid-in capital if such payments result in breaches of the prescribed and minimum capital requirement. See also Note 12.

 

v3.19.3
Taxation
9 Months Ended
Sep. 30, 2019
Income Tax Disclosure [Abstract]  
Taxation

Under current Cayman Islands law, no corporate entity, including the Company and the subsidiaries, is obligated to pay taxes in the Cayman Islands on either income or capital gains. The Company and its subsidiaries have an undertaking from the Governor-in-Cabinet of the Cayman Islands, pursuant to the provisions of the Tax Concessions Law, as amended, that, in the event that the Cayman Islands enacts any legislation that imposes tax on profits, income, gains or appreciations, or any tax in the nature of estate duty or inheritance tax, such tax will not be applicable to the Company and its subsidiaries or their operations, or to the ordinary shares or related obligations, until April 23, 2033 and May 17, 2033, respectively.

 

The Company and its subsidiaries intend to conduct substantially all of their operations in the Cayman Islands in a manner such that they will not be engaged in a trade or business in the U.S. However, because there is no definitive authority regarding activities that constitute being engaged in a trade or business in the U.S. for federal income tax purposes, the Company cannot assure that the U.S. Internal Revenue Service will not contend, perhaps successfully, that the Company or its subsidiary is engaged in a trade or business in the U.S. A foreign corporation deemed to be so engaged would be subject to U.S. federal income tax, as well as branch profits tax, on its income that is treated as effectively connected with the conduct of that trade or business unless the corporation is entitled to relief under an applicable tax treaty.

 

v3.19.3
Share-Based Compensation (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Share-based Payment Arrangement [Abstract]            
Number of options outstanding, beginning balance 540,000 540,000 250,000 250,000 250,000 250,000
Number of options, granted 290,000
Number of options outstanding, ending balance 540,000 540,000 540,000 250,000 250,000 250,000
Number of options exercisable, ending balance 291,250     208,125    
Weighted-average exercise price outstanding, beginning balance $ 3.86 $ 3.86 $ 0.00 $ 6.01 $ 6.01 $ 6.01
Weighted-average exercise price, granted 2.00
Weighted-average exercise price outstanding, ending balance 3.86 $ 3.86 $ 3.86 6.01 $ 6.01 $ 6.01
Weighted-average exercise price exercisable, ending balance $ 5.26     $ 6.01    
Weighted-average remaining contractual term, outstanding ending balance 7 years 7 months 6 days 7 years 10 months 24 days 8 years 1 month 6 days 6 years 8 months 12 days 6 years 10 months 24 days 7 years 2 months 12 days
Weighted-average remaining contractual term, exercisable ending balance 6 years 3 months 18 days     6 years 8 months 12 days    
Aggregate intrinsic value, outstanding ending balance $ 0 $ 0 $ 0 $ 0 $ 0 $ 0
Aggregate intrinsic value, exercisable ending balance $ 0     $ 0    
v3.19.3
Leases (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2019
Dec. 31, 2018
Sep. 30, 2018
Leases [Abstract]        
Operating lease cost [1] $ 22 $ 63    
Cash paid for amounts included in the measurement of lease liabilities - operating cash flows from operating leases 22 71    
Operating lease right-of-use assets 140 140 $ 0 $ 0
Operating lease liabilities $ 140 $ 140 $ 0 $ 0
Weighted-average remaining lease term - operating leases 4 years 5 months 1 day 4 years 5 months 1 day    
Weighted-average discount rate - operating leases 6.50% 6.50%    
[1] Includes short-term leases.
v3.19.3
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Ordinary Share Capital
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Total
Beginning balance, shares at Dec. 31, 2017 5,733,587        
Beginning balance at Dec. 31, 2017 $ 6 $ 32,100 $ (18,149) $ (39) $ 13,918
Cumulative effect of change in accounting for equity securities as of January 1, 2018     (22) 22 0
Net (loss) income for the period     (211)   (211)
Stock-based compensation   31     31
Total other comprehensive loss (income)       (3) (3)
Ending balance, shares at Mar. 31, 2018 5,733,587        
Ending balance at Mar. 31, 2018 $ 6 32,131 (18,382) (20) 13,735
Beginning balance, shares at Dec. 31, 2017 5,733,587        
Beginning balance at Dec. 31, 2017 $ 6 32,100 (18,149) (39) 13,918
Net (loss) income for the period         706
Total other comprehensive loss (income)         (3)
Ending balance, shares at Sep. 30, 2018 5,733,587        
Ending balance at Sep. 30, 2018 $ 6 32,194 (17,465) (20) 14,715
Beginning balance, shares at Mar. 31, 2018 5,733,587        
Beginning balance at Mar. 31, 2018 $ 6 32,131 (18,382) (20) 13,735
Net (loss) income for the period     265   265
Stock-based compensation   32     32
Total other comprehensive loss (income)       (1) (1)
Ending balance, shares at Jun. 30, 2018 5,733,587        
Ending balance at Jun. 30, 2018 $ 6 32,163 (18,117) (21) 14,031
Net (loss) income for the period     652   652
Stock-based compensation   31     31
Total other comprehensive loss (income)       1 1
Ending balance, shares at Sep. 30, 2018 5,733,587        
Ending balance at Sep. 30, 2018 $ 6 32,194 (17,465) (20) 14,715
Beginning balance, shares at Dec. 31, 2018 5,733,587        
Beginning balance at Dec. 31, 2018 $ 6 32,226 (23,920) 2 8,314
Net (loss) income for the period     (146)   (146)
Stock-based compensation   9     9
Total other comprehensive loss (income)       (2) (2)
Ending balance, shares at Mar. 31, 2019 5,733,587        
Ending balance at Mar. 31, 2019 $ 6 32,235 (24,066) 0 8,175
Beginning balance, shares at Dec. 31, 2018 5,733,587        
Beginning balance at Dec. 31, 2018 $ 6 32,226 (23,920) 2 8,314
Net (loss) income for the period         (366)
Total other comprehensive loss (income)         (2)
Ending balance, shares at Sep. 30, 2019 5,733,587        
Ending balance at Sep. 30, 2019 $ 6 32,253 (24,286) 0 7,973
Beginning balance, shares at Mar. 31, 2019 5,733,587        
Beginning balance at Mar. 31, 2019 $ 6 32,235 (24,066) 0 8,175
Net (loss) income for the period     (205)   (205)
Stock-based compensation   9     9
Total other comprehensive loss (income)         0
Ending balance, shares at Jun. 30, 2019 5,733,587        
Ending balance at Jun. 30, 2019 $ 6 32,244 (24,271) 0 7,979
Net (loss) income for the period     (15)   (15)
Stock-based compensation   9     9
Total other comprehensive loss (income)         0
Ending balance, shares at Sep. 30, 2019 5,733,587        
Ending balance at Sep. 30, 2019 $ 6 $ 32,253 $ (24,286) $ 0 $ 7,973
v3.19.3
Reserve for Losses and Loss Adjustment Expenses (Tables)
9 Months Ended
Sep. 30, 2019
Insurance [Abstract]  
Summary of loss and loss adjustment expenses
    Three Months Ended     Nine Months Ended  
    September 30,     September 30,  
    2019     2018     2019     2018  
    ($ in thousands)     ($ in thousands)  
                         
Balance, beginning of period   $ 107       167     $ 4,108       4,836  
Incurred related to:                                
     Current period     -       -       -       -  
     Prior period 1     -       -       -       (1,012 )
           Total incurred     -       -       -       (1,012 )
Paid related to:                                
     Current period     -       -       -       -  
     Prior period     -       -       (4,001 )     (3,657 )
           Total paid     -       -       (4,001 )     (3,657 )
Net balance, end of period   $ 107       167     $ 107       167  
Add: reinsurance recoverable       -       -       -       -  
Gross balance, end of period   $ 107       167     $ 107       167  
v3.19.3
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Statement of Financial Position [Abstract]    
Fixed-maturity securities, available for sale, at fair value amortized cost $ 0 $ 991
Equity securities, at fair value cost $ 612 $ 210
Ordinary shares, par value $ 0.001 $ 0.001
Ordinary shares, authorized 50,000,000 50,000,000
Ordinary shares, issued 5,733,587 5,733,587
Ordinary shares, outstanding 5,733,587 5,733,587
v3.19.3
Subsequent Events
9 Months Ended
Sep. 30, 2019
Subsequent Events [Abstract]  
Subsequent Events

We evaluate all subsequent events and transactions for potential recognition or disclosure in our consolidated financial statements. There were no other events subsequent to September 30, 2019 for which disclosure was required.

v3.19.3
Net Worth for Regulatory Purposes
9 Months Ended
Sep. 30, 2019
Net Worth For Regulatory Purposes  
Net Worth for Regulatory Purposes

The subsidiaries are subject to a minimum and prescribed capital requirement as established by CIMA. Under the terms of their respective licenses, Oxbridge Reinsurance Limited and Oxbridge Re NS are required to maintain a minimum and prescribed capital requirement of $500 in accordance with the relevant subsidiary’s approved business plan filed with CIMA.

 

At September 30, 2019, the Oxbridge Reinsurance Limited’s net worth of $1.5 million exceeded the minimum and prescribed capital requirement. For the three and nine-month periods ended September 30, 2019, the Subsidiary’s net loss was approximately $159 thousand and $754 thousand respectively.

 

At September 30, 2019, the Oxbridge Re NS’ net worth of $79 thousand exceeded the minimum and prescribed capital requirement. For the three and nine-month periods ended September 30, 2019, the Subsidiary’s net income was approximately $30 thousand and $61 thousand respectively.

 

The Subsidiaries are not required to prepare separate statutory financial statements for filing with CIMA, and there were no material differences between the Subsidiaries' GAAP capital, surplus and net income, and its statutory capital, surplus and net income as of September 30, 2019 or for the period then ended.

 

v3.19.3
Reserve for Losses and Loss Adjustment Expenses
9 Months Ended
Sep. 30, 2019
Insurance [Abstract]  
Resserve for Losses and Loss Adjustment Expenses

The following table summarizes the Company’s loss and loss adjustment expenses (“LAE”) and the reserve for loss and LAE reserve movements for the three and nine-month periods ending September 30, 2019 and 2018:

 

    Three Months Ended     Nine Months Ended  
    September 30,     September 30,  
    2019     2018     2019     2018  
    ($ in thousands)     ($ in thousands)  
                         
Balance, beginning of period   $ 107       167     $ 4,108       4,836  
Incurred related to:                                
     Current period     -       -       -       -  
     Prior period 1     -       -       -       (1,012 )
           Total incurred     -       -       -       (1,012 )
Paid related to:                                
     Current period     -       -       -       -  
     Prior period     -       -       (4,001 )     (3,657 )
           Total paid     -       -       (4,001 )     (3,657 )
Net balance, end of period   $ 107       167     $ 107       167  
Add: reinsurance recoverable       -       -       -       -  
Gross balance, end of period   $ 107       167     $ 107       167  

 

The reserves for losses and LAE are comprised of case reserves (which are based on claims that have been reported) and IBNR reserves (which are based on losses that are believed to have occurred but for which claims have not yet been reported and include a provision for expected future development on existing case reserves). The Company uses the assistance of an independent actuary in the determination of IBNR and expected future development of existing case reserves.

 

The uncertainties inherent in the reserving process and potential delays by cedants and brokers in the reporting of loss information, together with the potential for unforeseen adverse developments, may result in the reserve for losses and LAE ultimately being significantly greater or less than the reserve provided at the end of any given reporting period. The degree of uncertainty is further increased when a significant loss event takes place near the end of a reporting period. Reserve for losses and LAE estimates are reviewed periodically on a contract by contract basis and updated as new information becomes known. Any resulting adjustments are reflected in operations in the period in which they become known.

 

The Company’s reserving process is highly dependent on the timing of loss information received from its cedants and related brokers.

 

v3.19.3
Investments
9 Months Ended
Sep. 30, 2019
Investments, Debt and Equity Securities [Abstract]  
Investments

The Company from time to time invests in fixed-maturity securities and equity securities, with its fixed-maturity securities classified as available-for-sale. At September 30, 2019, the Company did not hold any available-for-sale securities. At December 31, 2018, the cost or amortized cost, gross unrealized gains and losses, and estimated fair value of the Company’s available-for-sale securities by security type were as follows:

 

   

Cost or
Amortized
Cost

   

Gross
Unrealized
Gain

   

Gross
Unrealized
Loss

   

Estimated
Fair
Value ($000)

 
    ($ in thousands)  
As of December 31, 2018                        
Fixed-maturity securities                        
U.S. Treasury and agency securities   $ 991     $ 2     $ -     $ 993  

 

At December 31, 2018, available-for-sale securities with fair value of $993,000, was held in trust accounts as collateral under reinsurance contacts with the Company’s ceding insurers.

 

All of the Company's available for sale securities had scheduled contractual maturities after one year and through five years at December 31, 2018.

 

There were no sales of available-for-sale fixed maturity or equity securities during the three-month period ended September 30, 2019. Proceeds received, and the gross realized gains and losses from sales of available-for-sale fixed-maturity securities, and equity securities, for the nine months ended September 30, 2019 and the three-months and nine-months ended September 30, 2018 were as follows:

 

    Gross proceeds
from sales
   

Gross
Realized
Gains

   

Gross
Realized
Losses

 
    ($ in thousands)  
                   
Nine Months Ended September 30, 2019                  
Available-for-sale fixed-maturity securities   $ 994     $ 3     $ -  
                         
Three Months Ended September 30, 2018                        
Available-for-sale fixed-maturity securities   $ 1,565     $ 3     $ -  
                         
Equity securities   $ 1,583     $ 57     $ (121 )
                         
Nine Months Ended September 30, 2018                        
Available-for-sale fixed-maturity securities   $ 4,565     $ 3     $ -  
                         
Equity securities   $ 7,616     $ 475     $ (715 )

 

The Company regularly reviews its individual investment securities for OTTI. The Company from time to time may hold debt securities or may consider various factors in determining whether each individual debt security is other-than-temporarily impaired, including:

 

the financial condition and near-term prospects of the issuer, including any specific events that may affect its operations or income;

 

the length of time and the extent to which the market value of the security has been below its cost or amortized cost;

 

general market conditions and industry or sector specific factors;

 

nonpayment by the issuer of its contractually obligated interest and principal payments; and

 

the Company’s intent and ability to hold the investment for a period of time sufficient to allow for the recovery of costs.

 

At December 31, 2018, there were no available-for-sale securities in an unrealized loss position.

 

Assets Measured at Estimated Fair Value on a Recurring Basis

 

The following table presents information about the Company’s financial assets measured at estimated fair value on a recurring basis that is reflected in the consolidated balance sheets at carrying value. The table indicates the fair value hierarchy of the valuation techniques utilized by the Company to determine such fair value as of September 30, 2019 and December 31, 2018:

 

   Fair Value Measurements Using   
   (Level 1)  (Level 2)  (Level 3)  Total
As of September 30, 2019  ($ in thousands)
Financial Assets:                    
Cash and cash equivalents  $6,137   $-   $-   $6,137 
                     
Restricted cash and cash equivalents  $1,915   $-   $-   $1,915 
                     
   Total equity securities   584    -    -    584 
                     
Total  $8,636   $-   $-   $8,636 

 

   Fair Value Measurements Using   
   (Level 1)  (Level 2)  (Level 3)  Total
As of December 31, 2018  ($ in thousands)
Financial Assets:                    
Cash and cash equivalents  $8,074   $-   $-  $8,074 
                     
Restricted cash and cash equivalents  $3,225   $-   $-   $3,225 
                     
U.S. Treasury and agency securities   -    993    -    993 
                     
                     
Total fixed-maturity securities   -    993    -    993 
                     
Total equity securities   162                  -    -    162 
                     
Total available for sale securities   162    993    -    1,155 
                     
Total  $11,461   $993   $-   $12,454 

 

There were no transfers between Levels 1, 2 and 3 during the three and nine months ended September 30, 2019 and 2018.

 

v3.19.3
Organization and Basis of Presentation (Details Narrative)
9 Months Ended
Sep. 30, 2019
Segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Equity method investment, ownership percentage 100.00%
Number of business operating segments 1
v3.19.3
Investments (Details 1) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Fixed Maturities      
Gross proceeds from sales $ 1,565   $ 4,565
Gross realized gains 3   3
Gross realized losses 0   0
Equity Securities      
Gross proceeds from sales 1,583 $ 994 7,616
Gross realized gains 57 3 475
Gross realized losses $ (121) $ 0 $ (715)
v3.19.3
Variable Interest Entities
9 Months Ended
Sep. 30, 2019
Variable Interest Entity, Measure of Activity [Abstract]  
Variable Interest Entities

Oxbridge Re NS. On December 22, 2017, the Company established Oxbridge Re NS, a Cayman domiciled and licensed special purpose insurer, formed to provide additional collateralized capacity to support Oxbridge Reinsurance Limited’s reinsurance business. In respect of the debt issued by Oxbridge Re NS to investors, Oxbridge Re NS has entered into a retrocession agreement with Oxbridge Reinsurance Limited effective June 1, 2018. Under this agreement, Oxbridge Re NS receives a quota share of Oxbridge Reinsurance Limited’s catastrophe business. Oxbridge Re NS is a non-rated insurer and the risks have been fully collateralized by way of funds held in trust for the benefit of Oxbridge Reinsurance Limited. Oxbridge Re NS is able to provide investors with access to diversified natural catastrophe risk backed by the distribution, underwriting, analysis and research expertise of Oxbridge Re.

 

The Company has determined that Oxbridge Re NS meets the definition of a VIE as it does not have sufficient equity capital to finance its activities. The Company concluded that it is the primary beneficiary and has consolidated the subsidiary upon its formation, as it owns 100% of the voting shares, 100% of the issued share capital and has a significant financial interest and the power to control the activities of Oxbridge Re NS that most significantly impacts its economic performance. The Company has no other obligation to provide financial support to Oxbridge Re NS. Neither the creditors nor beneficial interest holders of Oxbridge Re NS have recourse to the Company’s general credit.

 

Upon issuance of a series of participating notes by Oxbridge Re NS, all of the proceeds from the issuance are deposited into collateral accounts, to fund any potential obligation under the reinsurance agreements entered into with Oxbridge Reinsurance Limited underlying such series of notes. The outstanding principal amount of each series of notes generally is expected to be returned to holders of such notes upon the expiration of the risk period underlying such notes, unless an event occurs which causes a loss under the applicable series of notes, in which case the amount returned is expected to be reduced by such noteholder's pro rata share of such loss, as specified in the applicable governing documents of such notes. In addition, holders of such notes are generally entitled to interest payments, payable annually, as determined by the applicable governing documents of each series of notes. Oxbridge Re Holdings Limited receives an origination and structuring fee in connection with the formation, operation and management of Oxbridge Re NS.

 

Notes Payable to Series 2019-1 noteholders

 

Oxbridge Re NS entered into a retrocession agreement with Oxbridge Reinsurance Ltd on June 1, 2019 and issued $600 thousand of participating notes which provides quota share support for Oxbridge Re’s global property catastrophe excess of loss reinsurance business. The participating notes have been assigned Series 2019-1 and are due to mature on June 1, 2022. None of the participating notes were redeemed during the period ending September 30, 2019.

 

The income from Oxbridge Re NS operations that are attributable to the participating notes noteholders for the three and nine month ended September 30, 2019 was $70,000 and $94,000 respectively and are included within accounts payable and other liabilities as at September 30, 2019.

 

Notes Payable to Series 2018-1 noteholders

 

Oxbridge Re NS issued $2 million of participating notes on June 1, 2018, all of which were issued to third parties and which provides quota share support for Oxbridge Re’s global property catastrophe excess of loss reinsurance business. The operations of Oxbridge Re NS commenced on June 1, 2018. The participating notes were due to mature on June 1, 2021. However, during the quarter ending December 31, 2018, the participating notes were triggered, and suffered full loss, and as a result, these notes were subsequently redeemed and cancelled.

 

v3.19.3
Cash and Cash Equivalents and Restricted Cash and Cash Equivalents
9 Months Ended
Sep. 30, 2019
Cash and Cash Equivalents [Abstract]  
Cash and Cash Equivalents and Restricted Cash and Cash Equivalents
    At September 30,     At December 31,  
    2019     2018  
    (in thousands)  
             
Cash on deposit   $ 3,468     $ 3,965  
Cash held with custodians     2,669       4,109  
Restricted cash held in trust     1,915       3,225  
                 
Total   8,052     $  11,299  

 

Cash and cash equivalents are held by large and reputable counterparties in the United States of America and in the Cayman Islands. Restricted cash held in trust is custodied with SunTrust Bank and is held in accordance with the Company’s trust agreements with the ceding insurers and trustees, which require that the Company provide collateral having a market value greater than or equal to the limit of liability, less unpaid premium.

 

v3.19.3
Share-Based Compensation
9 Months Ended
Sep. 30, 2019
Share-based Payment Arrangement [Abstract]  
Share-Based Compensation

The Company currently has outstanding stock-based awards granted under the 2014 Omnibus Incentive Plan (the “Plan”). Under the Plan, the Company has discretion to grant equity and cash incentive awards to eligible individuals, including the issuance of up to 1,000,000 of the Company’s ordinary shares. At September 30, 2019, there were 400,000 shares available for grant under the Plan.

 

Stock options

 

The Company accounts for share-based compensation under the fair value recognition provisions of ASC Topic 718 – “Compensation – Stock Compensation.” Stock options granted and outstanding under the Plan vests quarterly over four years and are exercisable over the contractual term of ten years.

 

A summary of the stock option activity for the three and nine-month periods ended September 30, 2019 and 2018 is as follows:

 

   

Number

of

Options

   

Weighted-

Average

Exercise

Price

 

Weighted-

Average

Remaining

Contractual

Term

 

Aggregate

Intrinsic

Value

 
                     
Outstanding at January 1, 2019     250,000                
Granted     290,000     $ 2.00          
Outstanding at March 31, 2019     540,000     $ 3.86    8.1 years   $ -  
Outstanding at June 30, 2019     540,000     $ 3.86    7.9 years   $ -  
Outstanding at September 30, 2019     540,000     $ 3.86    7.6 years   $ -  
Exercisable at September 30, 2019     291,250     $ 5.26    6.3 years   $ -  
                           
                           
Outstanding at January 1, 2018     250,000     $ 6.01            
Outstanding at March 31, 2018     250,000     $ 6.01    7.2 years   $ -  
Outstanding at June 30, 2018     250,000     $ 6.01    6.9 years   $ -  
Outstanding at September 30, 2018     250,000     $ 6.01    6.7 years   $ -  
Exercisable at September 30, 2018     208,125     $ 6.01    6.7 years   $ -  

 

Compensation expense recognized for the three-month periods ended September 30, 2019 and 2018 totaled $9,000 and for the nine-month periods ended September 30, 2019 and 2018, totaled $27,000 and $29,000 respectively. Compensation expense is included in general and administrative expenses. At September 30, 2019 and 2018, there was approximately $95,000 and $25,000, respectively, of total unrecognized compensation expense related to non-vested stock options granted under the Plan. The Company expects to recognize the remaining compensation expense over a weighted-average period of thirty-three (33) months.

 

There were no options granted during the three and nine-month period ended September 30, 2018 and during the three months ended September 30, 2019. During the nine-month period ended September 30, 2019 the Company granted 290,000 options with fair value estimated on the date of grant using the following assumptions and the Black-Scholes option pricing model:

 

    2019  
       
Expected dividend yield     0 %
Expected volatility     31 %
Risk-free interest rate     3 %
Expected life (in years)     10  
Per share grant date fair value of options issued   $ 0.36  

 

At the time of the grant, the dividend yield was based on the Company’s history and expectation of dividend payouts at the time of the grant; expected volatility was based on volatility of similar companies’ common stock as described in Note 1; the risk-free rate was based on the U.S. Treasury yield curve in effect and the expected life was based on the contractual life of the options.

 

Restricted Stock Awards

 

The Company has granted and may grant restricted stock awards to eligible individuals in connection with their service to the Company. The terms of the Company’s outstanding restricted stock grants may include service, performance and market-based conditions. The fair value of any awards with market-based conditions is determined using a Monte Carlo simulation method, which calculates many potential outcomes for an award and then establishes fair value based on the most likely outcome. The determination of fair value with respect to the awards with only performance or service-based conditions is based on the value of the Company’s stock on the grant date.

 

During the three and nine-month periods ended September 30, 2019 and 2018, the Company did not grant any restricted stock. At September 30, 2019, there were no unvested restricted stock.

 

Compensation expense recognized for the three-month periods ended September 30, 2019 and 2018 totaled $0 and $22,000 respectively, and for the nine-month periods ended September 30, 2019 and 2018 totaled $0 and $65,000 respectively. Compensation expense is included in general and administrative expenses. At September 30, 2019 and 2018, there was approximately $0 and $22,000, respectively, of total unrecognized compensation expense related to non-vested restricted stock granted under the Plan.

 

v3.19.3
Significant Accounting Policies (Details Narrative)
9 Months Ended
Sep. 30, 2019
Furniture and Fixtures  
Fixed asset, estimated useful life 5 years
Computer Equipment  
Fixed asset, estimated useful life 5 years
Motor Vehicles  
Fixed asset, estimated useful life 4 years
v3.19.3
Investments (Details 2) - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Restricted cash and cash equivalents $ 1,915 $ 3,225
Total securities   1,155
Total 8,636 12,454
Fair Value, Measurements, Recurring    
Cash and cash equivalents 6,137 8,074
Restricted cash and cash equivalents 1,915 3,225
Fair Value, Measurements, Recurring | Fixed Maturities    
Total available-for-sale securities   993
Fair Value, Measurements, Recurring | Fixed Maturities | US Treasury and Government    
Total available-for-sale securities   993
Fair Value, Measurements, Recurring | Equity Securities    
Total equity securities 584 162
Fair Value, Inputs, Level 1    
Total securities   162
Total 8,636 12,454
Fair Value, Inputs, Level 1 | Fair Value, Measurements, Recurring    
Cash and cash equivalents 6,137 8,074
Restricted cash and cash equivalents 1,915 3,225
Fair Value, Inputs, Level 1 | Fair Value, Measurements, Recurring | Fixed Maturities    
Total available-for-sale securities   0
Fair Value, Inputs, Level 1 | Fair Value, Measurements, Recurring | Fixed Maturities | US Treasury and Government    
Total available-for-sale securities   0
Fair Value, Inputs, Level 1 | Fair Value, Measurements, Recurring | Equity Securities    
Total equity securities 584 162
Fair Value, Inputs, Level 2    
Total securities   993
Total 0 0
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring    
Cash and cash equivalents 0 0
Restricted cash and cash equivalents 0 0
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring | Fixed Maturities    
Total available-for-sale securities   993
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring | Fixed Maturities | US Treasury and Government    
Total available-for-sale securities   993
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring | Equity Securities    
Total equity securities 0 0
Fair Value, Inputs, Level 3    
Total securities   0
Total 0 0
Fair Value, Inputs, Level 3 | Fair Value, Measurements, Recurring    
Cash and cash equivalents 0 0
Restricted cash and cash equivalents 0 0
Fair Value, Inputs, Level 3 | Fair Value, Measurements, Recurring | Fixed Maturities    
Total available-for-sale securities   0
Fair Value, Inputs, Level 3 | Fair Value, Measurements, Recurring | Fixed Maturities | US Treasury and Government    
Total available-for-sale securities   0
Fair Value, Inputs, Level 3 | Fair Value, Measurements, Recurring | Equity Securities    
Total equity securities $ 0 $ 0
v3.19.3
Share-Based Compensation (Details 1) - Employee Stock Option
9 Months Ended
Sep. 30, 2019
$ / shares
Expected dividend yield 0.00%
Expected volatility 31.00%
Risk-free interest rate 3.00%
Expected life (in years) 10 years
Per share grant date fair value of options issued $ .36
v3.19.3
Leases (Details 1) - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Sep. 30, 2018
Leases [Abstract]      
Remainder 2019 $ 9 $ 0  
2020 36 0  
2021 36 0  
2022 37 0  
2023 37 0  
Thereafter 6 0  
Total future minimum lease payments 161 0  
Less imputed interest (21) 0  
Total operating lease liability $ 140 $ 0 $ 0
v3.19.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Operating activities    
Net (loss) income $ (366) $ 706
Adjustments to reconcile net (loss) income to net cash used in operating activities:    
Stock-based compensation 27 94
Net amortization of premiums on investments in fixed-maturity securities 0 7
Depreciation and amortization 7 14
Net realized investment (gains) losses (3) 237
Change in fair value of equity securities (20) (22)
Change in operating assets and liabilities:    
Accrued interest and dividend receivable 4 3
Premiums receivable (837) 1,718
Deferred policy acquisition costs (82) (143)
Prepayment and other receivables 1 45
Reserve for losses and loss adjustment expenses (4,001) (4,669)
Loss experience refund payable 0 (135)
Losses payable 0 (386)
Unearned premiums reserve 744 (272)
Accounts payable and other liabilities 87 589
Net cash used in operating activities (4,439) (2,214)
Investing activities    
Purchase of fixed-maturity securities 0 (4,902)
Purchase of equity securities (402) (5,804)
Proceeds from sale of fixed-maturity and equity securities 994 12,181
Net cash provided by investing activities 592 1,475
Financing activities    
Proceeds on issuance of notes payable to Series 2019-1 noteholders 600 2,000
Net cash provided by financing activities 600 2,000
Net change during the period (3,247) 1,261
Cash and cash equivalents, and restricted cash and cash equivalents at beginning of period 11,299 10,887
Cash and cash equivalents, and restricted cash and cash equivalents at end of period 8,052 12,148
Supplemental disclosure of cash flow information    
Interest paid 0 0
Income taxes paid 0 0
Non-cash transactions    
Net change in unrealized loss on securities available for sale (2) (3)
Operating lease right-of-use assets 140 0
Operating lease liability $ 140 $ 0
v3.19.3
Investments (Tables)
9 Months Ended
Sep. 30, 2019
Investments, Debt and Equity Securities [Abstract]  
Summary of available-for-sale securities
   

Cost or
Amortized
Cost

   

Gross
Unrealized
Gain

   

Gross
Unrealized
Loss

   

Estimated
Fair
Value ($000)

 
    ($ in thousands)  
As of December 31, 2018                        
Fixed-maturity securities                        
U.S. Treasury and agency securities   $ 991     $ 2     $ -     $ 993  
Summary of proceeds received, and gross realized gains and losses from sales of available-for-sale securities
    Gross proceeds
from sales
   

Gross
Realized
Gains

   

Gross
Realized
Losses

 
    ($ in thousands)  
                   
Nine Months Ended September 30, 2019                  
Available-for-sale fixed-maturity securities   $ 994     $ 3     $ -  
                         
Three Months Ended September 30, 2018                        
Available-for-sale fixed-maturity securities   $ 1,565     $ 3     $ -  
                         
Equity securities   $ 1,583     $ 57     $ (121 )
                         
Nine Months Ended September 30, 2018                        
Available-for-sale fixed-maturity securities   $ 4,565     $ 3     $ -  
                         
Equity securities   $ 7,616     $ 475     $ (715 )
Fair value of assets measured on recurring basis
    Fair Value Measurements Using    
    (Level 1)   (Level 2)   (Level 3)   Total
As of September 30, 2019   ($ in thousands)
Financial Assets:                                
Cash and cash equivalents   $ 6,137     $ -     $ -     $ 6,137  
                                 
Restricted cash and cash equivalents   $ 1,915     $ -     $ -     $ 1,915  
                                 
   Total equity securities     584       -       -       584  
                                 
Total   $ 8,636     $ -     $ -     $ 8,636  

 

    Fair Value Measurements Using    
    (Level 1)   (Level 2)   (Level 3)   Total
As of December 31, 2018   ($ in thousands)
Financial Assets:                                
Cash and cash equivalents   $ 8,074     $ -     $ -     $ 8,074  
                                 
Restricted cash and cash equivalents   $ 3,225     $ -     $ -     $ 3,225  
                                 
U.S. Treasury and agency securities     -       993       -       993  
                                 
                                 
Total fixed-maturity securities     -       993       -       993  
                                 
Total equity securities     162                     -       -       162  
                                 
Total available for sale securities     162       993       -       1,155  
                                 
Total   $ 11,461     $ 993     $ -     $ 12,454  

 

v3.19.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Assets    
Fixed-maturity securities, available for sale, at fair value (amortized cost of $991 in 2018) $ 0 $ 993
Equity securities, at fair value (cost of $612 and $210 respectively) 584 162
Total investments 584 1,155
Cash and cash equivalents 6,137 8,074
Restricted cash and cash equivalents 1,915 3,225
Accrued interest and dividend receivable 11 15
Premiums receivable 837 0
Deferred policy acquisition costs 82 0
Operating lease right-of-use assets 140 0
Prepayment and other assets 73 74
Property and equipment, net 11 18
Total assets 9,790 12,561
Liabilities:    
Reserve for losses and loss adjustment expenses 107 4,108
Notes payable to Series 2019-1 noteholders 600 0
Unearned premiums reserve 744 0
Operating lease liabilities 140 0
Accounts payable and other liabilities 226 139
Total liabilities 1,817 4,247
Shareholders' equity:    
Ordinary share capital, (par value $0.001, 50,000,000 shares authorized; 5,733,587 shares issued and outstanding) 6 6
Additional paid-in capital 32,253 32,226
Accumulated deficit (24,286) (23,920)
Accumulated other comprehensive loss 0 2
Total shareholders' equity 7,973 8,314
Total liabilities and shareholders' equity $ 9,790 $ 12,561
v3.19.3
Related Party Transactions
9 Months Ended
Sep. 30, 2019
Related Party Transactions [Abstract]  
Related Party Transactions

The Company had entered into reinsurance agreements with Claddaugh, which is a related entity through common directorships. At September 30, 2019 and December 31, 2018, there were no related-party amounts included within loss experience refund payable and unearned premium reserve on the consolidated balance sheets.

 

During the three and nine-month periods ended September 30, 2019 and 2018, included within change in loss experience refund payable and change in unearned premiums reserve on the consolidated statements of operations are the following related-party amounts:

 

    Three Months Ended     Nine Months Ended  
    September 30,     September 30,  
    2019     2018     2019     2018  
    (in thousands)     (in thousands)   
                         
Revenue                        
Assumed premiums     -       -       -       -  
Change in loss experience refund payable     -       -       -       (225 )
Change in unearned premiums reserve     -       -       -       592  

 

During the nine-month period ending September 30, 2019, Mr. Jay Madhu, a director and officer of the Company and its subsidiaries invested $50 thousand in Series 2019-1 participating notes.